| |
original article |
Date |
Title |
Authors Max. 6 Authors |
| 1 |
[GO] |
2024―Jul―11 |
19. Association between Genotype Variation with COVID-19 Severity in Hypertensive Patients: A Systematic Review and Meta-Analysis |
Rido Maulana, Ignatius Ivan, Bayushi Eka P, Renan Sukmawan, Bambang Widyantoro, Muhammad Fajri Adda’i, Anwar Santoso |
| 2 |
[GO] |
2024―May―22 |
LONG-TERM CHANGES IN ARTERIAL STIFFNESS AFTER COVID-19 |
Svetlana Bondar, Benjamin Granger, Alexandra Konradi |
| 3 |
[GO] |
2024―May―22 |
INFLUENCE OF ARTERIAL HYPERTENSION ON THE OCCURRENCE AND COURSE OF ATRIAL FIBRILLATION IN PATIENTS AFTER CORONAVIRUS DISEASE (COVID-19) |
Oksana Stasyshena, Oleg Sychov, Olena Marchenko, Tatiana Mikhalieva, Olena Torbas, Taisia Getman, Olena Romanova, Olga Sribna |
| 4 |
[GO] |
2024―May―22 |
ASSESSMENT OF THE RISK OF TROMBOSIS IN PATIENTS WITH ATRIAL FIBRILLATION AND CONCOMITANT ARTERIAL HYPERTENSION AFTER EXPERIENCING THE CORONAVIRUS DISEASE (COVID-19) |
Oksana Stasyshena, Oleg Sychov, Olena Romanova, Taisia Getman, Olga Sribna, Tatiana Mikhalieva, Olena Marchenko, Anna Solovian, Olena Torbas |
| 5 |
[GO] |
2024―May―22 |
COMPREHENSIVE PRE-DISCHARGE SYMPTOMS ASSESSMENT IN HYPERTENSIVE PATIENTS HOSPITALIZED FOR COVID-19 ALLOWS TO PREDICT PERSISTENCE OF SYMPTOMS AT 3 MONTHS |
Oleksii Honchar, Tetiana Ashcheulova |
| 6 |
[GO] |
2024―May―22 |
THE EFFECT OF COVID-19 ON NOCTURNAL BLOOD PRESSURE ELEVATION IN PATIENTS WITH ARTERIAL HYPERTENSION |
Munisa Atoeva, Guzal Abdullaeva, Khafiza Yusupova, Shukhrat Masharipov, Gulnoz Khamidullaeva |
| 7 |
[GO] |
2024―May―22 |
IMPACT OF COVID-19 ON THE PREVALENCE, AWARENESS AND CONTROL OF HYPERTENSION IN GREECE: MAY MEASUREMENT MONTH SURVEY 2019 VS 2022 |
Ariadni Menti, Anastasios Kollias, Eugenia Gkaliagkousi, Dimitrios Goumenos, Charalampos Grassos, Rigas G. Kalaitzidis, Manolis Kallistratos, Vasiliki Katsi, Dimitrios Konstantinidis, Vasileios Kotsis, Xenophon Krokidis, Konstantinos Kyriakoulis, Leonidas Lanaras, Emmanouil Makaris, Thomas Makris, Efstathios Manios, Spyridon Maragkoudakis, Athanasios Manolis, Maria Marketou, Charalampos Milionis, George Nikitas, Evangelos Papachristou, John Papadakis, Dimitrios Papadopoulos, Athanasios Protogerou, Maria Pikilidou, Pantelis Sarafidis, Vasilios Saraki, Konstantinos Tsoufis, Pantelis Zebekakis, Michael Doumas, George Stergiou |
| 8 |
[GO] |
2024―May―22 |
INFLUENCE OF COVID-19 ON VASCULAR REMODELING IN PATIENTS WITH ARTERIAL HYPERTENSION |
Guzal Abdullaeva, Munisa Atoeva, Khafiza Yusupova, Shukhrat Masharipov, Gulnoz Khamidullaeva |
| 9 |
[GO] |
2024―May―22 |
BLOOD PRESSURE CONTROL IN TERTIARY-CARE HYPERTENSIVE PATIENTS DURING COVID-19 PANDEMIC |
Anna Nieckarz, Jacek Wolf, Anna Panfil, Aleksandra Bialas, Julia Sternicka, Lukasz Jedrzejewski, Michal Hoffmann, Anna Szyndler, Aleksander Prejbisz, Michel Burnier, Krzysztof Narkiewicz |
| 10 |
[GO] |
2024―May―22 |
INADEQUATE CARE OF HYPERTENSION AND OTHER NON-COMMUNICABLE DISEASES DURING THE COVID-19 PANDEMIC IN SOUTH AFRICA |
Nasheeta Peer, Tshephang Mashiane, Sugitha Sureshkumar, Michel Oris, Kibachio Joseph Mwangi, Andre -Pascal Kengne |
| 11 |
[GO] |
2024―May―22 |
THE IMPACT OF THE COVID-19 PANDEMIC ON OFFICE AND 24-HOUR BLOOD PRESSURE PHENOTYPES (ESH ABPM COVID-19 STUDY) |
Aleksandra Ostrowska, Wiktoria Wojciechowska, Marek Rajzer, Kreutz Reinhold, Thomas Weber, Michael Bursztyn, Alexandre Persu, George Stergiou, Grzegorz Kielbasa, Gianfranco Parati, Grzegorz Bilo, Guido Grassi, Giuseppe Mancia, Andrzej Januszewicz |
| 12 |
[GO] |
2024―May―22 |
HYPERRENINISM - A COMMON PHENOMENON IN HOSPITALIZED COVID-19 PATIENTS |
Sebastian Bertram, Diana Racovitan, Bodo Hölzer, Benjamin Rohn, Adrian Doevelaar, Felix Seibert, Nina Babel, Timm Westhoff |
| 13 |
[GO] |
2024―May―22 |
IMPROVED ACCURACY OF LONG COVID-19 PREDICTION IN HOSPITALIZED HYPERTENSIVE PATIENTS COMPARED TO THE GENERAL COHORT |
Oleksii Honchar, Tetiana Ashcheulova |
| 14 |
[GO] |
2024―May―22 |
BIOMARKERS OF ENDOTHELIAL DYSFUNCTION AND CLOTTING DYSREGULATION POST COVID-19- A SUBSTUDY OF CARTESIAN |
Catherine Fortier, Mohsen Agharazii, Cécile Lakomy, Patrick Lacolley, Véronique Regnault |
| 15 |
[GO] |
2024―May―22 |
ARTERIAL HYPERTENSION AND COVID-19: A RETROSPECTIVE STUDY |
Nino Latsabidze |
| 16 |
[GO] |
2024―May―22 |
ANGIOGENIC MARKERS AS PROGNOSTIC TOOLS IN PATIENTS WITH COVID-19: CRACOV-HHS STUDY |
Katarzyna Stolarz-skrzypek, Agnieszka Olszanecka, Wiktoria Wojciechowsa, Piotr Kusak, Agnieszka Bednarek, Jakub Rusinek, Beata Kusnierz-cabala, Barbara Wizner, Andrzej Surdacki, Marek Sanak, Tomasz Grodzicki, Marek Rajzer |
| 17 |
[GO] |
2024―May―22 |
THE INFLUENCE OF CORONAVIRUS INFECTION ON THE DEGREE OF NOCTURNAL BLOOD PRESSURE ELEVATION IN PATIENTS WITH ARTERIAL HYPERTENSION |
Go’Zal Abdullayeva, Munisa Atoyeva, Khafiza Yusupova, Shukhrat Masharipov, Gulnoz Khamidullayeva |
| 18 |
[GO] |
2024―May―22 |
INFLUENCE OF CORONAVIRUS INFECTION ON VASCULAR REMODELING PARAMETERS IN PATIENTS WITH ARTERIAL HYPERTENSION |
Munisa Atoyeva, Go’Zal Abdullayeva, Khafiza Yusupova, Shuhrat Masharipov, Gulnoz Khamidullayeva |
| 19 |
[GO] |
2024―May―22 |
HYPERCOAGULATION OF BLOOD AND THROMBOCYTOPENIA AFTER SARS-COV-2 - PNEUMONIA AS PREDICTORS OF AN UNFAVORABLE PROGNOSIS IN PATIENTS WITH ARTERIAL HYPERTENSION |
Zheming Wang, Faiz Talibov, Elizaveta Zbyshevskaia, Tatiana Makeeva, Tamerlan Butaev, Fatima Bitakova |
| 20 |
[GO] |
2024―May―22 |
THE ROLE OF RIGHT VENTRICLE FUNCTIONALITY IN THE CARDIOPULMONARY STATUS OF HYPERTENSIVE PATIENTS HOSPITALIZED FOR SARS-COV-2 INFECTION |
Maria Kariori, Christos Fragkoulis, Christina Chysohoou, Panagiotis Tsioufis, Ioannis Andrikou, Kalliopi Grigoriou, Panteleimon Papakonstantinou, Maria Stathoulopoulou, Theodoros Kalos, Siafi Eirini, Fotios Tatakis, Eleni Manta, Panagiotis Iliakis, Emmanouel Mantzouranis, Dimitrios Konstantinidis, Costas Thomopoulos, Konstantinos Tsioufis |
| 21 |
[GO] |
2024―May―22 |
IMPACT OF SARS-COV-2 INFECTION IN NEUROCOGNITIVE AND CARDIOPULMONARY FUNCTIONALITY OF HYPERTENSIVE PATIENTS |
Maria Kariori, Christos Fragoulis, Christina Chrysohoou, Panagiotis Tsioufis, Kalliopi Grigoriou, Panteleimon Papakonstantinou, Fotios Tatakis, Maria Stathoulopoulou, Eirini Siafi, Lefki Nikolopoulou, Emmanouel Mantzouranis, Eleni Manta, Dimitrios Konstantinidis, Costas Thomopoulos, Konstantinos Tsioufis |
| 22 |
[GO] |
2024―May―22 |
LOW HIGH-DENSITY LIPOPROTEIN LEVEL PROMOTES INFLAMMATORY RESPONSE IN LONG COVID PATIENTS UNDERGOING HEMODIALYSIS ONE YEAR AFTER INFECTION |
Natalia Stepanova, Victoria Driianska, Andriy Rysyev, Lyudmyla Snisar, Daria Chernianu |
| 23 |
[GO] |
2024―Mar―25 |
Complete remission with histamine blocker in a patient with intractable hyperadrenergic postural orthostatic tachycardia syndrome secondary to long coronavirus disease syndrome |
Felipe González-Alvarez, Bruno Estañol, Jesús Antonio González-Hermosillo, Francisco Javier Gómez-Pérez, Karla Maria Tamez-Torres, Eduardo Peña, Carlos Cantú, Erwin Chiquete, José Sifuentes-Osornio, Maria del Carmen Alba-Lorenzo, Dulce Andrea Celestino-Montelongo, Guadalupe E. Salazar-Calderón, Jose de Jesus Aceves Buendia |
| 24 |
[GO] |
2023―Sep―08 |
Increased blood pressure after nonsevere COVID-19 |
Christian Schmidt-Lauber, Elisa Alba Schmidt, Sonja Hänzelmann, Elina L. Petersen, Christian-Alexander Behrendt, Raphael Twerenbold, Stefan Blankenberg, Tobias B. Huber, Ulrich O. Wenzel |
| 25 |
[GO] |
2023―Jun―20 |
Global blood pressure screening during the COVID-19 pandemic: results from the May Measurement Month 2021 campaign |
Thomas Beaney, Wei Wang, Markus P. Schlaich, Aletta E. Schutte, George S. Stergiou, Luis Alcocer, Jafar Alsaid, Alejandro Bimbo Diaz, Rafael Hernandez-Hernandez, Mohammad Ishaq, Jacek Jozwiak, Nadia Khan, Gaia Kiru, Harsha McCardle, Augustine Nonso Odili, Wook Bum Pyun, Cesar A. Romero, Jiguang Wang, Neil R. Poulter |
| 26 |
[GO] |
2023―Jun―08 |
USE OF ANTIHYPERTENSIVE DRUG CLASSES DURING THE COVID-19 PANDEMIC. A CROSS-SECTIONAL, NATION-WIDE STUDY 2019-2021 |
Piotr Dobrowolski, Aleksander Prejbisz, Gabriel Bozek, Beata Kon, Aneta Machnie, Filip Urbanski, Roman Topor Madry, Reinhold Kreutz, Andrzej Januszewicz, Maciej Milkowski |
| 27 |
[GO] |
2023―Jun―08 |
ASSOCIATION BETWEEN MASKED NOCTURNAL HYPERTENSION AND DEPRESSION DISORDER IN COVID-19 POSITIVE PATIENTS |
Jong Hoon Koh, Miyoung Kim, Minjong Kang |
| 28 |
[GO] |
2023―Jun―08 |
EFFECT OF COVID-19 ON BLOOD PRESSURE VARIABILITY IN HYPERTENSIVE PATIENTS |
Silviu Ionel Dumitrescu, Alice Munteanu, Silviu Stanciu, Ileana Hantulie, Raluca Popescu, Magdalena Gurzun, Ruxandra Ionescu, Diana Ciobanu, Serghei Cecoltan, Rares Boingiu, Irina Prisascariu |
| 29 |
[GO] |
2023―Jun―08 |
USE OF ANTIHYPERTENSIVE COMBINATION THERAPY DURING THE COVID-19 PANDEMIC - A CROSS-SECTIONAL, NATION-WIDE STUDY 2019-2021 |
Piotr Dobrowolski, Aleksander Prejbisz, Gabriel Bozek, Beata Kon, Aneta Machnio, Filip Urbanski, Roman Topor Madry, Reinhold Kreutz, Andrzej Januszewicz, Maciej Milkowski |
| 30 |
[GO] |
2023―Jun―08 |
ENDOTHELIAL FUNCTIONAL STATUS IN PATIENTS WITH HYPERTENSION AND TYPE 2 DIABETES MELLITUS AFTER COVID-19 |
Jamol Uzokov, Bakhromkhon Alyavi, Daler Orziev, Shakhboz Ubaydullaev |
| 31 |
[GO] |
2023―Jun―08 |
CARDIAC REMODELING IN HYPERTENSIVE PATIENTS WITH COVID-19: PRE-DISCHARGE ASSESSMENT AND A 1-MONTH FOLLOW-UP |
Oleksii Honchar |
| 32 |
[GO] |
2023―Jun―08 |
PRE-DISCHARGE SYSTOLIC BLOOD PRESSURE IN HOSPITALIZED COVID-19 PATIENTS IS AN INDEPENDENT PREDICTOR OF IMROVEMENT IN 6-MINUTE WALK TEST DURING 1-MONTH FOLLOW-UP |
Oleksii Honchar, Tetyana Ashcheulova |
| 33 |
[GO] |
2023―Jun―08 |
THE IMPACT OF COVID-19 PANDEMIC ON BLOOD PRESSURE CONTROL IN PATIENTS WITH TREATED HYPERTENSION. RESULTS OF EUROPEAN SOCIETY OF HYPERTENSION STUDY (ESH ABPM COVID-19 STUDY) |
Wiktoria Wojciechowska, Marek Rajzer, Thomas Weber, Marzena Chrostowska, Michalis Doumas, Jean -Baptiste De Fréminville, Jacek Lewandowski, Gregoire Wuerzner, Maria Gosk -Przybylek, Gianfranco Parati, Patricia Van Der Niepen, Thomas Kahan, Michael Bursztyn, Alexandre Persu, George S. Stergiou, Grzegorz Bilo, Guido Grassi, Giuseppe Mancia, Reinhold Kreutz, Andrzej Januszewicz |
| 34 |
[GO] |
2023―Jun―08 |
THE IMPACT OF HYPERTENSION AND OTHER COMORBIDITIES ON THE SEVERITY AND OUTCOME OF COVID-19 INFECTION IN SUDANESE HOSPITALIZED PATIENTS AT JABRA ISOLATION CENTRE 2021 |
Hind Beheiry, Marwa Elhassan, Zakarya Almarrani, Shehab Hazaa, Gaafar Abdulsamad, Doaa Ahmed, Mariam Moheieldin, Waleed Alhaj, Osman Farhan, Mohammed Jaber, Zein Ali, Hussam Elhadi, Shima Daffalla, Omar Abdelwahab, Ibtisam Ali, Mahasin Shaheen |
| 35 |
[GO] |
2023―Jun―08 |
COMORBIDITIES AND MORTALITY IN PATIENTS WITH COVID-19 AMONG AGED 18 YEARS AND OLDER IN DILCHORA HOSPITAL-DIRE DAWA, EASTERN ETHIOPIA, 2022 |
Dagmawi Abebe Ayele, Hirbo Shore Roba |
| 36 |
[GO] |
2023―Jun―08 |
COVID-19 AND MORTALITY IN HYPERTENSIVE PATIENTS ACCORDING TO CARDIORESPIRATORY FITNESS |
Charles Faselis, Michael Doumas, Andreas Pittaras, Immanuel Babu Samuel, Belinda Gorsuch, Alexandros Ladas, Carl Lavie, Jonathan Myers, Peter Kokkinos |
| 37 |
[GO] |
2023―Jun―08 |
EFFECT OF THE PERIOD OF THE COVID-19 PANDEMIC ON HYPERTENSIVE PEOPLE: A PROSPECTIVE COHORT STUDY |
Mayra Cristina Luz Pádua Guimarães, Juliano Santos, Juliana Chaves Coelho, Cassia Lima De Campos, Giovanio Vieira da Silva, Luciano Ferreira Drager, Angela Maria Geraldo Pierin |
| 38 |
[GO] |
2023―Jun―08 |
THE IMPACT OF THE 3-YEAR COVID-19 PANDEMIC IN THE HYPERTENSIVE POPULATION OF A EUROPEAN SOCIETY OF HYPERTENSION EXCELLENCE CENTER |
Helen Triantafyllidi, Dionyssia Birmpa, Dimitrios Benas, Anastasia Fambri, Dimitra Kavatha, Efstathios Iliodromitis |
| 39 |
[GO] |
2023―Jun―08 |
CLINICAL CONSEQUENCES IN POST COVID-19 HYPERTENSIVE PATIENTS |
Olena Matova, Larysa Mishchenko, Tatyana Talaeva, Volodymyr Bezrodnyj, Galina Bozhenko |
| 40 |
[GO] |
2023―Jun―08 |
POST HOC ERGO PROPTER HOC? NOT EVERYTHING THAT HAPPENS AFTER COVID-19 IS LONG COVID. OR, THE MANY MASQUERADES OF PHEOCHROMOCYTOMA |
Agnieszka Kuzior, Carlos Rios-Gomez, Borja Ojeda-Santana, Ricardo Jose de Leon-Durango, Alba Hernandez-Lazaro, Claudia Arnas-Leon, Carmen Acosta-Calero, Catherine Pino Ortiz-Hernandez, Jennifer Maria Perez-Rivero, Raul Rodriguez-Escobedo, Silvia Gonzalez-Martinez, Francisco Javier Martinez-Martin |
| 41 |
[GO] |
2023―Jun―08 |
COVID-19 AND ARTERIAL STIFFNESS IN VACCINATED YOUNG ADULTS WITHOUT PRIOR CO-MORBIDITIES. A CROSS-SECTIONAL ANALYSIS OF THE FIT@4COVID COHORT STUDY |
Telmo Pereira, Fábio Lira, Armando Caseiro, Joaquim Castanheira, Manuel Coelho-e-Silva |
| 42 |
[GO] |
2023―Jun―08 |
IMPACT OF THE COVID-19 PANDEMIC ON THE TREATMENT AND ADHERENCE OF HYPERTENSIVE PATIENTS: CHALLENGES AND OUTCOMES |
Roxana Pleava, Ilze Vinkele, Svetlana Mosteoru, Laura Gaita |
| 43 |
[GO] |
2023―Jun―08 |
DO RENIN-ANGIOTENSIN SYSTEM INHIBITORS HAVE ANY EFFECT ON THE SEVERITY OF COVID-19 IN HYPERTENSIVE SUBJECTS? |
Javier Nieto, José Abellán-Alemán, Maravillas Sánchez-Macarro, Ángeles Velasco-Soria, Rafael Crespo-Sabaris, Fernando García-Romanos, Francisco J. Fuentes-Jiménez, Jesús Iturralde-Iriso, Francisco Valls-Roca, Alcibiades S. Díaz-Vera, Javier Sobrino-Martínez, Manuel A. Gómez-Marcos |
| 44 |
[GO] |
2023―Jun―08 |
ONGOING ANTI-HYPERTENSIVE TREATMENT DOESN’T IMPACT ON OUTCOME ON MEDIUM-LONG TERM SEQUELAE OF PATIENTS WITH MODERATE TO SEVERE COVID-19 PNEUMONIA |
Chiara Cattaneo, Francesca Salvotti, Francesca Leidi, Riccardo Pellegrinelli, Veronica Geroldi, Giorgia Loro, Scilla Reale, Paola Vaccarello, Fabio Cherubini, Erika Borghi, Federico Napoli, Paolo Malerba, Carolina De Ciuceis, Claudia Agabiti Rosei, Damiano Rizzoni, Gianluca E.M. Boari |
| 45 |
[GO] |
2023―Jun―08 |
UNCONTROLLED BLOOD PRESSURE BEFORE COVID-19 IS ASSOCIATED WITH ELEVATED SERUM IL-17 AND LONG-COVID SEQUELAE IN HEMODIALYSIS PATIENTS |
Natalia Stepanova, Victoria Driianska, Andriy Rysyev, Tetyana Ostapenko, Nataliia Kalinina, Victoria Savchenko, Mykola Kolesnyk |
| 46 |
[GO] |
2023―Jun―08 |
HYPERTENSION AND RISK FACTOR TO MORTALITY IN CORONAVIRUS DISEASE (COVID-19) |
Monica Amorim de Oliveira, Andréa Haddad, Alessandra Godomiczer, Thaisa Rodrigues Garcia, Camila Sten, Flavia Pedro Moisés, Cristiane Comarck Ferraz, Eduardo Costa |
| 47 |
[GO] |
2023―Jun―08 |
PROTECTIVE EFFECTS OF CALCIUM CHANNEL BLOCKERS IN HYPERTENSIVE NON-VACCINATED PATIENTS WITH COVID-19 |
Milovan Stojanovic, Marina Deljanin Ilic, Ljiljana Trickovic, Sanja Stojanovic, Stevan Ilic |
| 48 |
[GO] |
2023―Jun―08 |
THE IMPACT OF ON-ADMISSION SYSTOLIC BLOOD PRESSURE READING ON THE SEVERITY AND CLINICAL OUTCOME OF HYPERTENSIVE COVID-19 HOSPITALIZED PATIENTS AT JABRA ISOLATION CENTRE/SUDAN: A CROSS-SECTIONAL HOSPITAL-BASED STUDY (2021) |
Hind M. Beheiry, Waleed M. Alhaj, Mohammed H. Jaber, Hazim H. Mohamed, Mohannad A. Almahie, Amjad M. Ahmed, Wadi Almadhoun, Mahmoud Hilali |
| 49 |
[GO] |
2023―Jun―08 |
DEMOGRAPHIC, CLINICAL CHARACTERISTICS AND IN-HOSPITAL OUTCOME OF HYPERTENSIVE COVID-19 POSITIVE PATIENTS |
Md Kalimuddin, Fazila-Tun-Nesa Malik, Mir Ishraquzzaman, Nazir Ahmed, Mohammad Badiuzzaman, Mir Nesaruddin Ahmed, Ashok Dutta, Dhiman Banik, Nazmun Laila, Md. Shamim Chowdhury |
| 50 |
[GO] |
2023―Jun―08 |
HYPERTENSIVE EMERGENCIES AND BLOOD PRESSURE CONTROL DURING THE COVID-19 PANDEMIC |
Ricardo Cabrera Solé, Caridad Turpin, Erik Luepke, Manuel Aguilera |
| 51 |
[GO] |
2023―Jun―08 |
COVID-19: RISK AND CARDIOVASCULAR DISEASE. SYSTEMATIC REVIEW 2022 |
Eulalia Amador Rodero, Santiago Rodriguez Miranda, Ana Maria Segura, Leslie Montealegre Esmeral, Martha Arteta Charris |
| 52 |
[GO] |
2023―Jun―08 |
ARTERIAL HYPERTENSION AND COVID-19: A RETROSPECTIVE STUDY |
Nino Latsabidze |
| 53 |
[GO] |
2023―Jun―08 |
LACK OF CARDIOVASCULAR EVENTS AFTER ONE YEAR FOLLOW-UP IN PATIENTS FOLLOWED HOSPITAL ADMISSION FOR MODERATE TO SEVERE COVID-19 PNEUMONIA |
Chiara Cattaneo, Francesca Salvotti, Francesca Leidi, Riccardo Pellegrinelli, Veronica Geroldi, Fabio Cherubini, Paola Vaccarello, Federico Napoli, Scilla Reale, Giorgia Loro, Daniele Turini, Paolo Malerba, Sara Viola, Giancarlo Pasini, Giulia Ferrari-Toninelli, Vittoria Guarinoni, Valeria Brami, Bianca Bonzi, Damiano Rizzoni, Gianluca E.M. Boari |
| 54 |
[GO] |
2023―Jun―08 |
MEDICAL STUDENTS’ EVALUATION BY SERIOUS GAME IN THE ERA OF COVID-19 INFECTION |
Ikram Chamtouri, Walid Jomaa, Khaldoun Ben Hamda |
| 55 |
[GO] |
2023―Jun―08 |
WHEN PERCUTANEOUS CORONARY INTERVENTION (PCI) IS NOT AN OPTION - CONSERVATIVE TREATMENT OF STEMI DUE TO THE CONTRAINDICATIONS AND SEVERE COVID-19 INFECTION |
Edyta Zbroch, Grzegorz Adasko, Marta Cabaj, Magdalena Barano, Aleksandra Zbroch, Julia Wawiernia, Aleksandra Zalewska, Agnieszka Zapora-Kurel |
| 56 |
[GO] |
2023―Jun―08 |
WHAT HAPPENED IN THE CARDIOLOGICAL OUTPATIENT PRACTICE AFTER THE COVID-19 PANDEMIA? |
Ivan Gruev, Veska Tsanova |
| 57 |
[GO] |
2023―Jun―08 |
CLINICAL COURSE OF COVID-19 DEPENDING ON PRESENCE OF HYPERTENSION AND BLOOD PRESSURE CONTROL |
Olexandr Kuryata, Yevheniia Frolova, Olexandr Stadnyk, Viktor Semenov |
| 58 |
[GO] |
2023―Jun―08 |
COVID-19 AND CARDIOVASCULAR COMPLICATIONS. AN INAUSPICIOUS COMBINATION |
Edyta Zbroch, Julia Waszak, Marcin Siwik, Jakub Bazarewicz, Weronika Piotrowska, Piotr Sielatycki |
| 59 |
[GO] |
2023―Jun―08 |
COVID-19 INFECTION IN PATIENTS WITH PROVEN HEART DISEASE |
Christian Ngongang Ouankou, Sylvain Raoul Simeni Njonnou, Liliane Mfeukeu Kuate, Claudine Jessica Yondo Ndedi, Marie Ida Chemgne, Fernando Kemta Lekpa, Merimee Ouankou, Simeon Pierre Choukem |
| 60 |
[GO] |
2023―Jun―08 |
FEATURES OF THE COURSE OF ATRIAL FIBRILLATION IN PATIENTS WITH CORONAVIRUS DISEASE |
Oksana Stasyshena, Oleg Sychov, Olena Romanova, Olena Marchenko |
| 61 |
[GO] |
2023―Jun―08 |
PECULIARITIES OF THE COURSE OF ATRIAL FIBRILLATION IN PATIENTS WITH ARTERIAL HYPERTENSION AFTER A CORONAVIRUS INFECTION |
Oksana Stasyshena, Oleg Sychov, Olena Romanova, Taisia Getman, Olga Sribna, Tatiana Mikhalieva, Olena Marchenko |
| 62 |
[GO] |
2023―Jun―08 |
BLOCK OF THE ANGIOTENSIN PATHWAYS EFFECTS FLOW-VOLUME SPIROMETRY IN PATIENTS WITH SARS-COV-2 INFECTION |
Francesca Mancini, Marialuisa Sveva Marozzi, Luciana Loponte, Antonio Giovanni Solimando, Angelo Vacca, Sebastiano Cicco |
| 63 |
[GO] |
2023―Jun―08 |
CARDIOPULMONARY STATUS AND RIGHT VENTRICLE FUNCTIONALITY IN HYPERTENSIVE PATIENTS HOSPITALIZED OR NOT FOR SARS-COV-2 INFECTION |
Maria Kariori, Christos Fragoulis, Christina Chrysochoou, Panagiotis Tsioufis, Kalliopi Grigoriou, Panteleimon Papakonstantinou, Nikolaos Mageiras, Eleni Manta, Lefki Nikolopoulou, Eirini Siafi, Emmanouil Mantzouranis, Fotios Tatakis, Dimitrios Konstantinidis, Costas Thomopoulos, Konstantinos Tsioufis |
| 64 |
[GO] |
2023―Jun―08 |
ELECTROLYTE IMBALANCES IN THE CONTEXT OF SARS-COV-2 INFECTION IN HYPERTENSIVE PATIENTS |
Cristiana Grigore, Beatrice Balaceanu, Cristian Dorin Gurau, Carmen Giuglea, Ion Dina, Alice Balaceanu |
| 65 |
[GO] |
2023―Jun―08 |
EFFECTS OF SARS-COV-2 INFECTION ON THE CARDIORESPIRATORY PERFORMANCE BY HYPERTENSION STATUS |
Maria Kariori, Christos Fragoulis, Christina Chrysochoou, Panagiotis Tsioufis, Kalliopi Grigoriou, Panteleimon Papakonstantinou, Nikolaos Mageiras, Eleni Manta, Lefki Nikolopoulou, Eirini Siafi, Emmanouil Mantzouranis, Fotios Tatakis, Dimitrios Konstantinidis, Costas Thomopoulos, Konstantinos Tsioufis |
| 66 |
[GO] |
2023―Jun―08 |
SYSTEMATIC LONG COVID SYMPTOMS ASSESSMENT IN HYPERTENSIVE AND NON-HYPERTENSIVE INDIVIDUALS DURING THE 12-MONTHS FOLLOW-UP AFTER HOSPITAL DISCHARGE |
Oleksii Honchar |
| 67 |
[GO] |
2023―May―17 |
Ups and downs of conducting a national representative survey on hypertension during pandemic time: main results of SEPHAR IV |
Maria Dorobantu, Cosmin Cojocaru, Laura Stanciulescu, Calin Pop, Cornelia Bala, Theodora Benedek, Irinel Parepa, Daniel Lighezan, Roxana Darabont, Dan Darabantiu, Florin Mitu, Valeriu Gheorghita, Alexandru Scafa-Udriste, Oana-Florentina Gheorghe-Fronea |
| 68 |
[GO] |
2023―Apr―25 |
56. Survival of COVID-19 Patients with Hypertension |
Dana Pramudya, Decsa Medika Hertanto, Artaria Tjempakasari |
| 69 |
[GO] |
2023―Apr―25 |
25. Hypertension as the Main Comorbidity Diseases in Covid-19 Patients with Diabetes Mellitus: A Single Centre in North Sumatera, Indonesia |
R.A. Muzasti, M. Situmorang |
| 70 |
[GO] |
2023―Apr―25 |
12. Predicting Mortality in COVID-19 Patients with Hypertension using ECLA Score (ECG, Chest X-Ray and Laboratory Analysis) |
P.K. Lituhayu, A. Regina, A.F. Theno, A.D. Lamara, P.B.T. Saputra, M.J. Al-Farabi, Y. Azmi, M.E. Saputra, Y.H. Oktaviono |
| 71 |
[GO] |
2023―Apr―25 |
13. Abnormal Cardiac Finding Increases Mortality Risk in Hypertensive COVID-19 Patients |
P.K. Lituhayu, A. Regina, A.F. Theno, A.D. Lamara, P.B.T. Saputra, M.J. Al-Farabi, Y. Azmi, M.E. Saputra, Y.H. Oktaviono |
| 72 |
[GO] |
2023―Apr―05 |
Impaired β2-adrenergic endothelium-dependent vasodilation in patients previously hospitalized with coronavirus disease 2019 |
Luca Faconti, Bushra Farukh, Ryan J. McNally, Sally Brett, Phil J. Chowienczyk |
| 73 |
[GO] |
2023―Jan―12 |
PS-P06-1: REDUCED HEALTHCARE UTILIZATION AMONG PATIENTS WITH CHRONIC DISEASES DURING THE PANDEMIC |
Anuji Upekshika Gamage, Therani Gunasekera, Amala de Silva |
| 74 |
[GO] |
2023―Jan―12 |
PS-P06-2: HEALTHCARE EXPENDITURE AND CARE SEEKING PATTERNS AMONG PEOPLE WITH CHRONIC CONDITIONS DURING THE PANDEMIC |
Anuji Upekshika Gamage, Therani Gunasekera, Amala de Silva |
| 75 |
[GO] |
2023―Jan―12 |
PS-C16-12: IS ARTERIAL HYPERTENSION A MODIFIER OF CARDIOPULMONARY EXERCISE TEST AND ECHOCARDIOGAPHIC FINDINGS AFTER HOSPITALIZATION FOR SARS-COV-2? |
Maria Kariori, Christos Fragkoulis, Christina Chrysochoou, Dimitrios Konstantinidis, Ioannis Leontsinis, Ioannis Andrikou, Panagiotis Iliakis, Emmanouil Mantzouranis, Konstantinos Konstantinou, Theodoros Kalos, Kalliopi Grigoriou, Costas Thomopoulos, Costas Tsioufis |
| 76 |
[GO] |
2023―Jan―12 |
S-39-3: ENDOTHELIAL INFLAMMATION AND DYSFUNCTION INDUCED BY SARS-COV-2 SPIKE PROTEIN 1 INVOLVE ADAM17 AND INTERFERON ACTIVATION PATHWAYS |
Francisco J Rios, Augusto C Montezano, Livia L Camargo, Rheure A Lopes, Ana B Garcia Redondo, Eliju Aranday Cortes, Ana M Briones, John McLauchlan, Rhian M Touyz |
| 77 |
[GO] |
2023―Jan―12 |
PS-C16-11: PREVALENCE AND HOSPITAL OUTCOME OF BACTERIAL CO-INFECTION IN RESPIRATORY TRACT SPECIMEN AMONG COVID 19 PATIENTS WITH SARS-COV-2 PNEUMONIA |
Dianne Joy Capuz Soliman |
| 78 |
[GO] |
2023―Jan―12 |
S-39-4: PLASMA FROM SARS-COV-2 PATIENTS INDUCES OXIDATIVE STRESS AND ENDOTHELIAL DYSFUNCTION VIA ANGIOTENSIN II TYPE 1 RECEPTOR (AT1R)/P38 MAPK PATHWAY |
Moudhi Almutlaq, Fatmah A Mansour, Hassan S Alamri, Fayhan Alroqi, Tlili Barhoumi |
| 79 |
[GO] |
2023―Jan―12 |
PS-C16-13: CARDIORESPIRATORY STATUS AFTER SARS-COV-2 INFECTION: THE ROLE OF HYPERTENSION AS RISK FACTOR |
Maria Kariori, Christos Fragoulis, Dimitrios Polyzos, Eirini Siafi, Fotis Tatakis, Ioannis Zamanis, Maria Kouremeti, Ioannis Leontsinis, Sotirios Drogkaris, Eleni Manta, Kalliopi Grigoriou, Kyriakos Dimitriadis, Dimitrios Konstantinidis, Costas Thomopoulos, Costas Tsioufis |
| 80 |
[GO] |
2023―Jan―12 |
PS-C30-12: IMPACT OF SARS-COV-2 INFECTION TO RISK AND SEVERITY OF HYPERTENSION IN PREGNANCY AND ITS OUTCOME TO THE NEW BORN |
I Gusti Bagus Mulia Agung Pradnyaandara, I Gde Sastra Winata, I Wayan Artana Putra |
| 81 |
[GO] |
2023―Jan―12 |
S-18-4: ACE2 IS INVOLVED IN SARS-COV-2 INDUCED ENDOTHELIAL CELL INFLAMMATION INDEPENDENT OF VIRAL REPLICATION |
Augusto Montezano, Livia L Camargo, Sheon Mary, Karla B Neves, Francisco J Rios, Rheure A Lopes, Wendy Beattie, Imogen Herbert, Vanessa Herder, Agnieszka M Szemiel, Steven McFarlane, Massimo Palmarini, David Bhella, Rhian M Touyz |
| 82 |
[GO] |
2023―Jan―12 |
PS-BPC10-8: POST-VACCINATION SARS-COV-2 IGG ANTIBODY TITER IN DIALYSIS PATIENTS |
Sumiko Yoshida, Seijirou Tsuji, Keiko Miya, Hisato Shima, Manabu Tashiro, Tomoko Inoue, Jun Minakuchi, Kazuyoshi Okada, Itsuro Endo, Masahiro Abe |
| 83 |
[GO] |
2023―Jan―12 |
PS-R05-1: CASE REPORT: A RARE CASE OF ALVEOLAR HEMORRHAGE AFTER COVID-19 VACCINATION IN A PATIENT WITH RENAL-LIMITED ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY-ASSOCIATED VASCULITIS |
Ken Nishioka, Shintaro Yamaguchi, Itaru Yasuda, Norifumi Yoshimoto, Daiki Kojima, Kenji Kaneko, Mitsuhiro Aso, Tomoki Nagasaka, Eriko Yoshida, Kiyotaka Uchiyama, Takaya Tajima, Jun Yoshino, Tadashi Yoshida, Takeshi Kanda, Hiroshi Itoh |
| 84 |
[GO] |
2023―Jan―12 |
PS-C16-6: POSTAL MEDICINE DELIVERY FOR STAGE-2 HYPERTENSIVE PATIENTS IN COVID-19 SITUATION: TURNING CRISIS TO OPPORTUNITY |
Thapanawong Mitsungnern, Sathorn Ponpong, Nipa Udonjarut, Supap Imoun, Praew Kotruchin |
| 85 |
[GO] |
2023―Jan―12 |
PS-C16-5: RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM INHIBITORS AND CLINICAL OUTCOMES IN COVID-19 PATIENTS WITH HYPERTENSION:A REPORT OF THREE PEAK WAVE PERIODS IN SEMARANG, INDONESIA |
Niyata Hananta Karunawan, Iin Irnawati Jusuf, Alvin Tonang, Prihatin Iman Nugroho |
| 86 |
[GO] |
2023―Jan―12 |
PS-C16-7: ASSOCIATION OF ELECTROCARDIOGRAM FINDINGS WITH MORTALITY IN COVID-19 PATIENTS |
Achilles Aquino, Marian Lopez |
| 87 |
[GO] |
2023―Jan―12 |
PS-P06-3: TREATMENT SEEKING BEHAVIOUR AND TRIGGERS AMONG PATIENTS WITH CHRONIC ILLNESSES DURING COVID-19 PANDEMIC: A QUALITATIVE STUDY |
Anuji Gamage, Therani Gunasekera, Sridharan Sathasivam |
| 88 |
[GO] |
2023―Jan―12 |
PS-C16-14: EFFECT OF THE COVID-19 PANDEMIC ON AMBULATORY BLOOD PRESSURE MEASUREMENT |
Daryl Tcheutchoua Nzokou, Martin Chaumont, Philippe Van de Borne |
| 89 |
[GO] |
2023―Jan―12 |
PS-C13-3: MORTALITY RATE AND REDUCTION OF HOSPITALIZATION FOR ACUTE MYOCARDIAL INFARCTION IN RESEARCH INSTITUTE OF CARDIOLOGY<RIC>,BAKU IN COVID-19 PANDEMIC |
Zaur Ismayil Gasimov, Gulnaz Dadashova, Tarana Javadova, Tavakkul Yusifov |
| 90 |
[GO] |
2023―Jan―12 |
PS-C16-8: CONSEQUENCES OF DISCONTINUING ANTIHYPERTENSIVE TREATMENT DURING THE FIRST WAVE OF A COVID-19 PANDEMIC |
Anna Vachulova, Lubos Urban, Slavomira Filipova |
| 91 |
[GO] |
2023―Jan―12 |
S-42-6: COVID-19 MORTALITY CORRELATES WITH CHRONIC DISEASE BURDEN AMONG COUNTRIES’ ONGOING SOCIAL DEVELOPMENT |
Shuichiro Araki |
| 92 |
[GO] |
2023―Jan―12 |
JS-MT-1: MAINTAINING AN ACTIVE RESEARCH CAREER DURING COVID-19 LOCKDOWNS |
Yugeesh R Lankadeva |
| 93 |
[GO] |
2023―Jan―12 |
PS-C16-4: COMPARATIVE EFFICACY OF VARIOUS ANTICOAGULANTS IN COVID-19 INDIAN SUBJECTS: AN OBSERVATIONAL STUDY |
Hariharan Ranga Satya Munganda, Dnyanesh Amle, Satyanarayana Chowdary Ponnaganti, Gopalakrishna Murthy Tirumalsetty, Aparna Devi Vvl |
| 94 |
[GO] |
2023―Jan―12 |
PS-P12-11: INFECTION CONTROL PRACTICES OF HEALTHCARE WORKERS INFECTED WITH COVID-19 IN TONDO MEDICAL CENTER FROM MARCH 2020 TO MAY 2021 |
Sheryl Joy Esteban Gracilla, Joseph Quebral |
| 95 |
[GO] |
2023―Jan―12 |
PS-BPC06-4: RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM INHIBITORS VERSUS CALCIUM CHANNEL BLOCKERS IN ASSOCIATION WITH MORTALITY RATE IN COVID-19 HYPERTENSIVE PATIENTS: THE EFFECT OF AGE |
Dina Ahmed Hassan, Maha Ismail Elamin, Intisar Abdelrahim Bashir, Tarig Elhadi Mahmoud |
| 96 |
[GO] |
2023―Jan―12 |
S-39-5: FACTORS AFFECTING DEVELOPMENT OF AKI AMONG COVID-19 HYPERTENSIVE PATIENTS |
Intisar Abdelrahim Bashir Omer, Maha Esmail Elamin, Dina Ahmed Hasan |
| 97 |
[GO] |
2023―Jan―12 |
S-39-1: COVID-19 AND HYPERTENSION IN JAPAN, AND KANAGAWA RASI COVID-19 STUDY |
Kouichi Tamura, Yasushi Matsuzawa, Kazuo Kobayashi |
| 98 |
[GO] |
2023―Jan―12 |
PS-BPC06-1: RENIN-ANGIOTENSIN SYSTEM BLOCKER AND THE COVID-19 AGGRAVATION: REPORT BY THE COVID-19 REGISTRY JAPAN |
Fumiki Yoshihara, Hiroshi Ohtsu, Michikazu Nakai, Shinya Tsuzuki, Kayoko Hayakawa, Mari Terada, Nobuaki Matsunaga, Satoshi Yasuda, Hisao Ogawa, Norio Ohmagari |
| 99 |
[GO] |
2023―Jan―12 |
PS-C16-2: ASSESS THE TREATMENT ADHERENCE OF ANTIHYPERTENSIVE MEDICATIONS DURING COVID-19, A MULTICENTER CENTER STUDY OF PAKISTAN |
Mudassar Iqbal Arain, Eduardo Fricovsky, Saira Shahnaz, Ramesha Anwar |
| 100 |
[GO] |
2023―Jan―12 |
PS-C16-3: HYPERTENSION AND RISK FACTORS ASSOCIATED WITH IN-HOSPITAL DEATH IN PATIENTS WITH COVID-19 |
maha Ismail Elamin, Dina Ahmed Hassan, Intisar Abdelrahim Bashir, Tarig E Mahmoud |
| 101 |
[GO] |
2023―Jan―12 |
APSH-OP-1: THERAPEUTIC TARGET AND CLINICAL IMPACT OF DAY-TO-DAY BLOOD PRESSURE VARIABILITY IN HYPERTENSIVE PATIENTS WITH COVID-19 |
Gusti Ngurah Prana Jagannatha, AA Ayu Dwi Adelia Yasmin, I Wayan Agus Surya Pradnyana, Stanly Kamardi, Elionardo Enrique Pangkahila |
| 102 |
[GO] |
2023―Jan―12 |
AW-NI-1: ANGIOTENSIN II EXAGGERATES SARS-COV-2 SPECIFIC T-CELL RESPONSE IN CONVALESCENT INDIVIDUALS FOLLOWING COVID-19 |
Moudhi Almutlaq, Fatmah A Mansour, Hassan S Alamri, Fayhan Alroqi, Tlili Barhoumi |
| 103 |
[GO] |
2023―Jan―12 |
PS-C16-1: COURSE OF ACS IN PATIENTS CO-INFECTED WITH COVID-19 |
Khurshid Fozilov, Bakhtiyor Atamuratov, Bakhtiyor Yuldashov, Sherzod Butaev, Alisher Yuldashov |
| 104 |
[GO] |
2022―Sep―02 |
Coronavirus disease 2019 infection and subsequent cardiovascular complications |
Tomoyuki Kawada |
| 105 |
[GO] |
2022―Aug―11 |
The effects of hypertension on the prognosis of coronavirus disease 2019: a systematic review and meta-analysis on the interactions with age and antihypertensive treatment |
Alimamy Umaru Kabia, Ping Li, Zhichao Jin, Xiaojie Tan, Yilong Liu, Yuqi Feng, Keyao Yu, Ming Hu, Dongming Jiang, Guangwen Cao |
| 106 |
[GO] |
2022―Aug―09 |
Stay alert about coagulation parameters - implications of thrombosis treatment in COVID-19: Erratum |
|
| 107 |
[GO] |
2022―Aug―09 |
Preeclampsia and severe acute respiratory syndrome coronavirus 2 infection: a systematic review |
Giovanni Tossetta, Sonia Fantone, Nicola delli Muti, Giancarlo Balercia, Andrea Ciavattini, Stefano Raffaele Giannubilo, Daniela Marzioni |
| 108 |
[GO] |
2022―Jun―28 |
Severe COVID-19 infection and cardiovascular disease - a long-term relationship or short myocardial affair? |
Manish Motwani |
| 109 |
[GO] |
2022―Jun―14 |
ENDOTHELIAL COMPLICATIONS IN HYPERTENSIVE PATIENTS WITH OBESITY OR NORMAL BODY WEIGHT AFTER COVID-19 |
Izolda Kokaeva, Yulia Zhernakova, Natalia Blinova, Eugenia Elfimova, Olga Pogorelova, Maria Tripoten, Irina Chazova |
| 110 |
[GO] |
2022―Jun―14 |
ASSOCIATION OF IN-PATIENT OUTCOMES AND RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM INHIBITOR USE AMONG HYPERTENSIVE PATIENTS WITH CORONAVIRUS DISEASE 2019 (COVID-19) |
Ma. Cecilia Lozada, Henry Medina, Ma Sergia Fatima Sucaldito, Lourdes Ella Santos, Deborah Ignacia David-Ona, Raymond Oliva |
| 111 |
[GO] |
2022―Jun―14 |
THE PROGNOSTIC VALUE OF THE BIOLOGICAL PROFILE OF INFLAMMATION AND COAGULATION AT HYPERTENSIVE PATIENTS AFTER COVID-19 |
Adrian Gavrila |
| 112 |
[GO] |
2022―Jun―14 |
THE FEATURE OF ATRIAL FIBRILLATION OCCURRENCE AND PROGRESSION IN PATIENTS WITH ARTERIAL HYPERTENSION, WHO HAVE UNDERGONE COVID-19 |
Lusine Hazarapetyan, Svetlana Grigoryan, Parunak Zeveian |
| 113 |
[GO] |
2022―Jun―14 |
ARTERIAL HYPERTENSION FOLLOWING COVID-19 |
Didi Delalic, Juraj Jug, Vamsi Varahabhatla, Ingrid Prkacin |
| 114 |
[GO] |
2022―Jun―14 |
OPTIMIZATION OF BLOOD PRESSURE CONTROL AND ANGIOPROTECTION WITH FIXED COMBINATION OF LISINOPRIL + AMLODIPINE + ROSUVASTATIN IN PATIENTS AFTER A COVID-19 |
Sergey Nedogoda, Alla Ledyaeva, Elena Chumachek, Vera Tsoma, Alla Salasyuk, Viktoriya Lutova, Ekaterina Popova, Daniil Vlasov, Olga Bychkova, Viktoriya Labaznikova, Konstantin Evdokimov |
| 115 |
[GO] |
2022―Jun―14 |
IMPAIRED BETA-2ADRENERGIC ENDOTHELIUM-DEPENDENT VASODILATION IS REVERSED BY PHOSPHODIESTERASE INHIBITION IN PATIENTS PREVIOUSLY HOSPITALIZED WITH COVID-19 |
Luca Faconti, Bushra Farukh, Ryan McNally, Sally Brett, Philip Chowienczyk |
| 116 |
[GO] |
2022―Jun―14 |
DYNAMICS OF ECHOCARDIOGRAPHY CHARACTERISTICS OF THE MYOCARDIUM IN PATIENTS WITH CONFIRMED DIAGNOSIS OF COVID-19 |
Larisa Minushkina, Tatyana Davydova, Natalya Chuprik, Anna Snigirova |
| 117 |
[GO] |
2022―Jun―14 |
STAY ALERT ABOUT COAGULATION PARAMETERS - IMPLICATIONS OF THROMBOSIS TREATMENT IN COVID-19 |
Piotr Sielatycki, Edyta Zbroch, Martyna Markowska, Aleksandra Zalewska, Aleksandra Bowtruczuk, Jedrzej Warpecowski, Malgorzata Gryciuk |
| 118 |
[GO] |
2022―Jun―14 |
ELEVATED RESTING HEART RATE AS INDEPENDENT IN-HOSPITAL PROGNOSTIC MARKER IN COVID-19 |
Gino Serravalle, Jennifer Vanoli, Raffaella Dell’Oro, Giacomo Marro, Rita Facchetti, Fosca Quarti-Trevano, Domenico Spanziani, Guido Grassi |
| 119 |
[GO] |
2022―Jun―14 |
COLCHICINE FOR THE PREVENTION OF COVID-19 “HARD” OUTCOMES: ALL THAT GLITTERS IS NOT GOLD. AN UPDATED ANALYSIS OF RANDOMIZED CONTROLLED TRIALS |
Dimitrios Patoulias, Alexandra Katsimardou, Konstantinos Imprialos, Konstantinos Stavropoulos, Christodoulos Papadopoulos, Michael Doumas |
| 120 |
[GO] |
2022―Jun―14 |
TREATMENT WITH BLOCKERS OF THE RENIN-ANGIOTENSIN SYSTEM DOES NOT AFFECT RENAL FUNCTION IN PATIENTS WITH SEVERE COVID-19 ADMITTED TO INTENSIVE CARE UNIT |
Francesco Salvo, Elisa Gallo, Anna Botto, Alessio Risoli, Paolo Parola, Rita Tenio, Ilaria Nicoletti, Paolo Valesano, Ilaria Blangetti, Alberto Morganti |
| 121 |
[GO] |
2022―Jun―14 |
COVID-19 AND CARDIOVASCULAR SYSTEM: NOT ONLY HEART BUT ALSO VASCULAR. THE EFFECTS OF THE INFECTION ON ARTERIAL STIFFNESS |
Alessandro Maloberti, Elena Gualini, Sara Scarpellini, Michela Algeri, Marco Biolcati, Enzo Grasso, Chiara Tognola, Antonella Moreo, Saverio Fabbri, Cristina Giannattasio |
| 122 |
[GO] |
2022―Jun―14 |
COVID-19 AND NEW ONSET HYPERTENSION |
Evgeniya Shalaeva, Maksuda Shamsutdinova, Alisher Shadmanov, Shukhrat Boymuradov, Feruza Azizova, Dilshod Allaberganov, Hugo Saner, Franz Messerli |
| 123 |
[GO] |
2022―Jun―14 |
COVID-19 ASSOCIATED REDUCTION IN HYPERTENSION-RELATED DIAGNOSTIC AND THERAPEUTIC PROCEDURES IN EXCELLENCE CENTERS OF THE EUROPEAN SOCIETY OF HYPERTENSION |
Thomas Weber, Reinhold Kreutz, Andrzej Januszewicz, Christopher Mayer, Konstantinos Tsioufis, György Abraham, Jaques Amar, Istvan Barna, Weimer Kunz Sebba Barroso, Tine De Backer, Marcus van der Giet |
| 124 |
[GO] |
2022―Jun―14 |
GLOMERULAR HYPERFILTRATION MAY CONTRIBUTE TO RENAL TROPISM AND KIDNEY INJURY IN COVID-19 BY UPREGULATING ACE2 IN HUMAN PODOCYTES |
Juliane Bolbrinker, Eva Mangelsen, Aikaterini Kourpa, Kaiser Debora, Panakova Daniela, Kreutz Reinhold |
| 125 |
[GO] |
2022―Jun―14 |
THE COURSE OF ATRIAL FIBRILLATION AFTER A PREVIOUS INFECTION WITH COVID-19 DEPENDING ON THE PRESENCE OF ARTERIAL HYPERTENSION |
Oleg Sychov, Oksana Stasyshena, Olena Ilchyshyna, Yu Zinchenko, Taisiya Getman, Olena Romanova, Olga Sribna |
| 126 |
[GO] |
2022―Jun―14 |
COVID-19 IMPACT ON THE PREVALENCE OF SUBCLINICAL HYPERTENSION AMONG PRACTICALLY HEALTHY MEDICAL STUDENTS |
Yulia Yufereva, Oleg Shevchenko, Leonid Ginzburg, Artem Zakirzyanov, Alex Shevchenko |
| 127 |
[GO] |
2022―Jun―14 |
DETERMINANTS OF OUTCOME OF MODERATE TO SEVERE COVID-19 IN A HOSPITAL SETTING: A COMPARISON BETWEEN FIRST AND SECOND/THIRD WAVE IN LOMBARDY |
Gianluca Boari, Francesca Leidi, Beatrice Accordini, Federico Napoli, Chiara Ghidelli, Giulia Archenti, Giulia Chiarini, Paolo Malerba, Ottavio Scarano, Benedetta Mangili, Giulia Gorla, Andrea Corbani, Silvia Bonetti, Federico Braglia-Orlandini, Gianluca Bianco, Cristina Faustini, Giulia Ferrari-Toninelli, Daniele Turini, Vittoria Guarinoni, Michele Saottini, Franscesca Manzoni, Claudia Agabiti Rosei, Carolina De Ciuceis, Damiano Rizzoni |
| 128 |
[GO] |
2022―Jun―14 |
COVID-19 INFECTION AND ARTERIAL HYPERTENSION - A RECIPROCAL INTERACTION? |
Filipa Ferreira Rodrigues, Juliana Sá |
| 129 |
[GO] |
2022―Jun―14 |
COVID-19 IS ASSOCIATED WITH ENDOTHELIAL DYSFUNCTION: A META-ANALYSIS OF OBSERVATIONAL STUDIES |
Dimitrios Patoulias, Alexandra Katsimardou, Konstantinos Stavropoulos, Konstantinos Imprialos, Asterios Aidinis, Asimina Sviggou, Vasilios Kordalis, Athina Pyrpasopoulou, Christodoulos Papadopoulos, Michael Doumas |
| 130 |
[GO] |
2022―Jun―14 |
ANGIOTENSIN-CONVERTING ENZYME INHIBITORS AND ANGIOTENSIN II RECEPTOR BLOCKERS AS A RISK FACTOR FOR PATIENTS HOSPITALIZED WITH COVID-19. IS THAT TRUE? |
Paula Luque, Luis Castilla-Guerra, Maria Ferrary, Nieves Sanchez, Maria Alegre, Eduardo Carmona, Miguel Angel Rico |
| 131 |
[GO] |
2022―Jun―14 |
SELF-REPORTED CHANGE IN (UN)HEALTHY BEHAVIOURS OF PATIENTS WITH CARDIOVASCULAR DISEASES DURING THE SECOND COVID-19 LOCKDOWN IN NORTHERN GREECE: FOCUS ON DIABETES |
Antonios Ioannidis, Apostolos Pechlevanis, Afroditi Fragkiskou, Filio Asmani |
| 132 |
[GO] |
2022―Jun―14 |
PHYSICAL ACTIVITY AND LIFESTYLE CHANGES IN ITALY DURING THE COVID-19 LOCKDOWN: GENDER DIFFERENCES |
Alessio Pellegrino, Martina Rosselli, Melissa Orlandi, Maria Boddi, Laura Stefani, Loira Toncelli, Pietro Amedeo Modesti |
| 133 |
[GO] |
2022―Jun―14 |
ASSESSMENT OF ADHERENCE TO ANTIHYPERTENSIVE MEDICATION IN A POPULATION OF ARGENTINA DURING THE COVID-19 PANDEMIC |
Nicolas Renna, Emiliano Diez, Sergio Vissani, Beder Farez, Viviana Sorasio, Belen Camaño, Martha Alcorta, Roberto Miatello, Jesica Ramirez |
| 134 |
[GO] |
2022―Jun―14 |
LEVERAGING TECHNOLOGY TO SUPPORT PEOPLE LIVING WITH HYPERTENSION AND DIABETES DURING THE COVID-19 PANDEMIC |
Aima Adebo Uagboe, Ayoposi Ogboye, Maria Moosa Munee, Km Jawadur Rahman, Jonas Kofi Akpakli, Nneka Mobisson |
| 135 |
[GO] |
2022―Jun―14 |
BLOOD PRESSURE CONTROL RATES PREVIOUS AND DURING THE COVID-19 PANDEMIC IN BRAZIL |
Lucas Lima, Priscila Vitorino, Suelen Silva, Ana Sousa, Weimar Barroso |
| 136 |
[GO] |
2022―Jun―14 |
IMPACT OF THE COVID-19 PANDEMIC ON THE INITIATION OF ANTIHYPERTENSIVE DRUG THERAPY IN FRANCE |
Valérie Olié, Clemence Grave, Philippe Tuppin, Thomas Lesuffleur, Charles Guenancia, Jacques Blacher, Amélie Gabet |
| 137 |
[GO] |
2022―Jun―14 |
EFFECT OF THE COVID-19 PANDEMIC ON THE NYCHTHEMERAL BLOOD PRESSURE PROFILE |
Daryl Tcheutchoua Nzokou, Phillipe van de Borne, Martin Chaumont |
| 138 |
[GO] |
2022―Jun―14 |
LATVIA’S DOCTORS EXPERIENCE ON PROVIDING REMOTE CONSULTATIONS DURING COVID-19 PANDEMICS |
Aleksandra Jeniceka, Dzintra Homka, Ieva Bikava, Sevinç Elif Sen, Emma Sokolova |
| 139 |
[GO] |
2022―Jun―14 |
CONTINUOUS REMOTE PATIENT MONITORING SHOWS EARLY CARDIOVASCULAR CHANGES IN COVID-19 PATIENTS |
Arik Eisenkraft |
| 140 |
[GO] |
2022―Jun―14 |
CONTINUES REMOTE CARDIAC MONITORING IN CRITICALLY ILL COVID-19 PATIENTS (C3 STUDY) |
Avinash Hanbe Rajanna, Jeetendra Kumar |
| 141 |
[GO] |
2022―Jun―14 |
IMPACT OF ARTERIAL HYPERTENSION AND ANTIHYPERTENSIVE PHARMACOTHERAPY ON IN-HOSPITAL MORTALITY IN COVID-19 PATIENTS: THE CRACOV-HHS STUDY |
Wiktoria Wojciechowska, Michal Terlecki, Marek Klocek, Andrzej Januszewicz, Tomasz Grodzicki, Reinhold Kreutz, Marek Rajzer |
| 142 |
[GO] |
2022―Jun―14 |
AORTIC STIFFNESS AND INDEXES OF DISEASE SEVERITY IN SUBJECTS WITH PREVIOUS COVID-19 PNEUMONIA: A FOLLOW-UP STUDY |
Valeria Baiano, Cristiana Catena, Luca Bulfone, Laura Scandolin, Antonio Vacca, Gabriele Brosolo, Andrea Da Porto, Alessandro Cavarape, Gianluca Colussi, Nicole Bertin, Cinzia Vivarelli, Leonardo Sechi |
| 143 |
[GO] |
2022―Jun―14 |
COVID-19 RELATED CHANGE IN DAILY LIFE OF HYPERTENSIVE PATIENTS MAY AFFECT HYPERTENSION MANAGEMENT |
Vasiliki Tsoutsouli, Zacharo Sachla, Kyprianos Efstathiou, Dimos Foutsitsakis, Alexander James Damianos, Konstantinos Gkogkos |
| 144 |
[GO] |
2022―Jun―14 |
SHORT-TERM BLOOD PRESSURE ALTERATIONS AFTER COVID-19 VACCINATION |
Elias Sanidas, Dimitrios Papadopoulos, Theoharis Anastasiou, Maria Velliou, Eftixia Michalaki, Anastasia Fotsali, Spyretta Golemati, Marina Mantzourani, John Barbetseas |
| 145 |
[GO] |
2022―Jun―14 |
ACUTE MYOCARDITIS FOLLOWING COVID-19 VACCINATION: A PECULIAR CASE SERIES |
Sara Corradetti, Matteo Sclafani, Raffaella Mistrulli, Giovanna Gallo, Erika Pagannone, Marco Di Girolamo, Camillo Autore, Massimo Volpe, Allegra Battistoni |
| 146 |
[GO] |
2022―Jun―14 |
THE EFFECT OF COVID-19 VACCINE ON ARTERIAL FUNCTION |
Dimitrios Terentes-Printzios, Vasiliki Gardikioti, Eirini Solomou, Eleni Emmanouil, Ioanna Gourgouli, Panagiotis Xydis, Georgia Christopoulou, Christos Georgakopoulos, Ioanna Dima, Antigoni Miliou, George Lazaros, Maria Pirounaki, Konstantinos Tsioufis, Charalambos Vlachopoulos |
| 147 |
[GO] |
2022―Jun―14 |
FACTORS THAT INFLUENCE THE SURVIVAL RATE IN PATIENTS WITH COVID-19 WITH A PREVIOUS DIAGNOSIS OF HYPERTENSION AND/OR DIABETES: A SYSTEMATIC REVIEW |
Leslie Montealegre, Eulalia Amador, Tammy Pulido, Roberto Rebolledo, Lisbeth Olvera, Brenda Pacheco |
| 148 |
[GO] |
2022―Jun―14 |
SELF-ASSESSMENT OF VITAL SIGNS AND SYMPTOMS OF COVID-19: BLOOD PRESSURE MEASUREMENTS RESULTS FROM THE HYTECC STUDY |
André Michaud, Lyne Cloutier, Alain Vadeboncoeur, Rémi Goupil |
| 149 |
[GO] |
2022―Jun―14 |
EFFECT OF HYPERTENSION AND RAS INHIBITORS TO ADULT PATIENTS (OVER 18 YEARS OLD) WITH SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (SARS-COV2) INFECTION WHO WERE ADMITTED TO HOSPital |
Imola Fejes, Richárd Róka, György Ábrahám, Tamás Várkonyi, Csaba Lengyel, Péter Légrády |
| 150 |
[GO] |
2022―Jun―14 |
CORONAVIRUS DISEASE-2019 IS ASSOCIATED WITH ARTERIAL STIFFNESS IMPAIRMENT: A META-ANALYSIS OF OBSERVATIONAL STUDIES |
Dimitrios Patoulias, Alexandra Katsimardou, Konstantinos Imprialos, Konstantinos Stavropoulos, Asimina Sviggou, Asterios Aidinis, Vasilios Kordalis, Athina Pyrpasopoulou, Christodoulos Papadopoulos, Michael Doumas |
| 151 |
[GO] |
2022―Jun―14 |
FEATURES OF THE PARAMETERS OF RED BLOOD CELLS AND HEMOSTASIS IN PATIENTS WITH STROKES ASSOCIATED WITH CORONAVIRUS INFECTION |
Margarita Vitali Kruchinina, Andrey Alexandro Gromov, Vladimir Mikhail Generalov, Anna Vladimirovn Rabko |
| 152 |
[GO] |
2022―Jun―14 |
THE ROLE OF BLOOD PRESSURE LEVEL IN THE DEVELOPMENT OF ATRIAL FIBRILLATION AFTER CORONAVIRUS INFECTION |
Oksana Stasushena |
| 153 |
[GO] |
2022―Jun―14 |
EFFECT OF CORONAVIRUS INFECTION ON PATIENTS WITH CONTROLLED AND UNCONTROLLED ARTERIAL HYPERTENSION |
Anastasiya Denisova, Olga Sivakova, Tatyana Solntseva, Irina Chazova |
| 154 |
[GO] |
2022―Jun―14 |
IMMUNE DYSREGULATION INDUCED BY SPIKE PROTEIN 1 OF SARS-COV-2 INCREASES ENDOTHELIAL CELL DYSFUNCTION VIA TYPE I AND TYPE III INTERFERON ACTIVATION PATHWAYS |
Francisco J. Rios, Augusto C. Montezano, Livia L. Camargo, Rheure A. Lopes, Ana B. Garcia-Redondo, Eliju Aranday-Cortes, Ana M. Briones, John Mclauchlan, Rhian M. Touyz |
| 155 |
[GO] |
2022―Jun―14 |
ATRIAL FIBRILLATION INCIDENCE IN SARS-COV-2 INFECTED PATIENTS: PREDICTORS AND RELATIONSHIP WITH IN-HOSPITAL MORTALITY |
Alessandro Maloberti, Cristina Giannattasio, Paola Rebora, Giuseppe Occhino, Nicola Ughi, Jacopo Rizzo, Saverio Fabbri, Filippo Leidi, Iside Cartella, Michela Algeri, Sara Scarpellini, Claudio Rossetti, Oscar Epis, Giulio Molon, Paolo Bonfanti, Maria Grazia Valsecchi, Simonetta Genovesi |
| 156 |
[GO] |
2022―Jun―14 |
IMPACT OF HYPERTENSION AS AN ADDITIONAL RISK FACTOR IN CARDIORESPIRATORY STATUS OF POST SARS-COV-2 INFECTED SUBJECTS |
Maria Kariori, Christos Fragoulis, Dimitrios Polyzos, Ioannis Leontsinis, Kalliopi Grigoriou, Sotirios Drogkaris, Eleni Manta, Fotis Tatakis, Ioannis Zammanis, Maria Kouremeti, Eirini Siafi, Dimitrios Konstantinidis, Kyriakos Dimitriadis, Costas Thomopoulos, Konstantinos Tsioufis |
| 157 |
[GO] |
2022―Jun―14 |
CLINICAL AND MORPHOLOGICAL FEATURES OF KIDNEY DAMAGE IN PATIENTS WITH ARTERIAL HYPERTENSION DIED OF SARS-COV-2 INFECTION |
Tatiana Makeeva, Elizaveta Zbyshevskaya, Fatima Bitakova, Vadim Erinchek, Sergey Saiganov, Oksana Zaytseva, Vladislav Nechaev, Elena Sivtsova, Mark Mayer, Faiz Talibov |
| 158 |
[GO] |
2022―Jun―14 |
IMPAIRED ACE2 GLYCOSYLATION AND PROTEASE ACTIVITY LOWERS SUSCEPTIBILITY TO SARS-COV-2 INFECTION IN GITELMAN/BARTTER SYNDROMES |
Giovanni Bertoldi, Verdiana Ravarotto, Luca Sgarabotto, Laura Gobbi, Lucia Federica Stefanelli, Lorenzo A. Calò |
| 159 |
[GO] |
2022―Jun―14 |
PARTICULARITIES OF HYPERTENSIVE PATIENTS WITH METABOLIC SYNDROME, ADMITTED FOR SARS-COV-2 INFECTION TO A CLINICAL EMERGENCY HOSPITAL |
Raluca Stirban, Cristiana Grigore, Doina Dragoi, Beatrice Balaceanu, Cristian-Dorin Gurau, Cornelia Voiculet, Magda Zaharia, Giorgiana Dediu, Octavian Zara, Carmen Giuglea, Camelia Calin, Ion Dina, Alice Balaceanu |
| 160 |
[GO] |
2022―Jun―14 |
MICROCIRCULATION AND SARS-COV-2 INFECTION: A FOLLOW UP STUDY |
Paolo Malerba, Claudia Agabiti Rosei, Giulia Chiarini, Matteo Nardin, Alina Petelca, Andrea Gaggero, Matteo Lemoli, Francesca Famà, Gianluca Edoardo Boari, Mattia Baresi, Nicolò Bondioli, Enzo Porteri, Anna Paini, Massimo Salvetti, Maria Lorenza Muiesan, Damiano Rizzoni, Carolina De Ciuceis |
| 161 |
[GO] |
2022―Jun―14 |
IT IS SOMETHING MAKING THE DIFFERENCE BETWEEN HYPERTENSIVE PATIENTS WITH METABOLIC SYNDROME VERSUS HYPERTENSIVE PATIENTS WITHOUT METABOLIC SYNDROME IN SARS-COV-2 INFECTION? |
Raluca Stirban, Doina Dragoi, Cristiana Grigore, Beatrice Balaceanu, Cristian-Dorin Gurau, Cornelia Voiculet, Magda Zaharia, Octavian Zara, Giorgiana Dediu, Carmen Giuglea, Camelia Calin, Ion Dina, Alice Balaceanu |
| 162 |
[GO] |
2022―Jun―14 |
COMPARISON BETWEEN FIRST AND SECOND/THIRD WAVE OF SARS-COV-2 MODERATE TO SEVERE INFECTION IN ELDERLY PATIENTS IN AN NORTH ITALIAN HOSPITAL SETTING |
Gianluca Boari, Francesca Leidi, Beatrice Accordini, Benedetta Mangili, Chiara Ghidelli, Giulia Archenti, Giulia Chiarini, Paolo Malerba, Giulia Gorla, Andrea Corbani, Ottavio Scarano, Federico Napoli, Silvia Bonetti, Federico Braglia-Orlandini, Cristina Faustini, Gianluca Bianco, Giulia Ferrari-Toninelli, Daniele Turini, Vittoria Guarinoni, Michele Saottini, Francesca Manzoni, Alessandra Marengoni, Claudia Agabiti Rosei, Carolina De Ciuceis, Damiano Rizzoni |
| 163 |
[GO] |
2022―Jun―14 |
CARDIOPULMONARY EXERCISE TEST AND ECHOCARDIOGAPHIC FINDINGS IN HOSPITALISED POST SARS-COV-2 PATIENTS: THE EFFECT OF ARTERIAL HYPERTENSION |
Maria Kariori, Christos Fragoulis, Christina Chrysochoou, Ioannis Leontsinis, Emmanoyil Mantzouranis, Panagiotis Iliakis, Dimitrios Konstantinidis, Konstantinos Konstantinou, Ioannis Andrikou, Theodoros Kalos, Kalliopi Grigoriou, Konstantinos Tsioufis |
| 164 |
[GO] |
2022―Jun―14 |
NEW ONSET OF HYPERTENSION IN PATIENTS ADMITTED FOR INFECTION WITH SARS-COV-2 VIRUS |
Raluca Stirban, Cristiana Grigore, Doina Dragoi, Beatrice Balaceanu, Cristian-Dorin Gurau, Cornelia Voiculet, Magda Zaharia, Octavian Zara, Gelu Popa, Carmen Giuglea, Camelia Calin, Ion Dina, Alice Balaceanu |
| 165 |
[GO] |
2022―Jun―14 |
THE IMPACT OF HYPERTENSION AND ANTIHIPERTENSIVE TREATMENTS ON PATIENTS WITH SARS-COV-2: A RETROSPECTIVE-COHORT STUDY |
Paula Luque, Luis Castilla-Guerra, Nieves Sanchez, Maria Delgado, Maria Alegre, Eduardo Carmona, Miguel Angel Rico |
| 166 |
[GO] |
2022―Jun―14 |
IS HOME BLOOD PRESSURE SELF MONITORING HERE TO STAY? AN EVALUATION OF PATIENT SATISFACTION WITH HOME BLOOD PRESSURE MONITORING IN A RURAL POPULATION DURING THE COVID PANDEMIC |
Anjali Patel, Reshma Rasheed, Ahmad Zarif, Azad Mahmod, Hajira Bibi, Imad Nazir |
| 167 |
[GO] |
2022―Jun―14 |
MUSIC THERAPY WITH HYPERTENSIVE PATIENTS DURING THE PANDEMIC PERIOD - ONLINE MEETINGS AS PART OF MULTIPROFESSIONAL TREATMENT |
Claudia Zanini, Diana Teixeira, Dalma Pereira, Ana Luiza L. Sousa, Weimar K.S.B. Souza |
| 168 |
[GO] |
2022―Jun―14 |
TELEMEDICINE AND HEALTH POLICY CHANGES IN RESPONSE TO RESTRICTIONS RELATED TO COVID-19 PANDEMICS IN LATVIA |
Sevinc Elif Sen, Emma Sokolova, Aleksandra Jeniceka, Ieva Bikava |
| 169 |
[GO] |
2022―Jun―14 |
RED BLOOD CELL COLOUR VARIATION AS A MARKER OF CALCIUM DISTRIBUTION: WHAT ROLE DOES IT HAVE IN HEART FAILURE PATIENTS WITH HYPERTENSION AND LONG COVID? |
Yulian Kyya, Olga Barnett, Marta Halkevych, Olha Labinska |
| 170 |
[GO] |
2022―May―17 |
42 BLOOD PRESSURE DURING INFECTION AND SERUM CREATININE CONCENTRATIONS PREDICT SEVERE DISEASE IN COVID-19 |
I. Gde Raka Widiana, I. Made Bagiada, Wira Mahandita |
| 171 |
[GO] |
2022―May―17 |
7 IMPACT OF DAY-TO-DAY BLOOD PRESSURE VARIABILITY TO IN-HOSPITAL MORTALITY IN PATIENTS WITH COVID-19 AND EFFICACY OF ANTIHYPERTENSIVE AGENTS |
G.N.P. Jagannatha, I.W.A.S. Pradnyana, S. Kamardi, A.A.A.D.A. Yasmin |
| 172 |
[GO] |
2022―May―17 |
13 THE ROLE OF HYPERTENSION AS A RISK FACTOR FOR ACUTE KIDNEY INJURY IN COVID-19 AT RSUP HAJI ADAM MALIK MEDAN: A CROSS-SECTIONAL STUDY IN 2020 |
Mutia Chairani, Annisa Nidya Rahmatika Sitepu, Riri Andri Muzasti |
| 173 |
[GO] |
2022―May―17 |
11 NEWLY-DIAGNOSED HYPERTENSION DURING ADMISSION FOR COVID-19 CARE AND ITS SUBSEQUENT EFFECT ON OUTCOME OF TREATMENT: A PROSPECTIVE COHORT STUDY |
M.A. Sholehuddin, M.A.R. Firmansya, N.H.R. Ilahi, K. Wahyuni, A. Lutfiyah, W.K. Ilahi |
| 174 |
[GO] |
2022―May―17 |
25 HYPERTENSION AND MORTALITY PREDICTOR WITHIN 10 DAYS AMONG END-STAGE RENAL DISEASE WITH COVID-19 INFECTION |
Langgeng Perdhana, Shofa Chasani, Muchlis Achsan Udji Sofro |
| 175 |
[GO] |
2022―May―17 |
Virtual management of hypertension: lessons from the COVID-19 pandemic-International Society of Hypertension position paper endorsed by World Hypertension League and European Society of Hypertension |
Nadia A. Khan, George S. Stergiou, Stefano Omboni, Kazuomi Kario, Nicolas Renna, Niamh Chapman, Richard J. McManus, Bryan Williams, Gianfranco Parati, Aleksandra Konradi, Shariful M. Islam, Hiroshi Itoh, Ching S. Mooi, Bev B. Green, Myeong-Chan Cho, Maciej Tomaszewski |
| 176 |
[GO] |
2022―May―17 |
16 OBSERVING PATIENTS' NON-ADHERENCE TO HYPERTENSION CONTROL DURING COVID-19 PANDEMIC: A QUALITATIVE STUDY IN THE PUBLIC HEALTH CENTER SETTING |
I Putu Hendri Aryadi, Made Martha Pradnyana, Made Ayu Hapsari Dwi Ambarini, I Gusti Ayu Nila Kusumawati. |
| 177 |
[GO] |
2022―May―17 |
43 CHARACTERISTICS AND MORTALITY IN HYPERTENSIVE COVID-19 PATIENTS AT A DISTRICT HOSPITAL IN NORTH JAKARTA: A CROSS-SECTIONAL STUDY |
Tantika Andina, Marcel H.R. Sibarani |
| 178 |
[GO] |
2022―May―17 |
39 CHARACTERISTICS AND MORTALITY IN HYPERTENSIVE COVID-19 PATIENTS AT A DISTRICT HOSPITAL IN NORTH JAKARTA: A CROSS-SECTIONAL STUDY |
Tantika Andina, Marcel H.R. Sibarani |
| 179 |
[GO] |
2022―May―17 |
46 ANGIOTENSIN-CONVERTING ENZYME INHIBITORS/ANGIOTENSIN RECEPTOR BLOCKER IMPROVES CLINICAL OUTCOMES IN COVID-19 PATIENTS: A META-ANALYSIS |
Bayushi Eka Putra, Bambang Widyantoro, Rido Maulana, Agnes Dinar Putrinarita, Bhayu Hanggadhi Nugroho, Anwar Santoso |
| 180 |
[GO] |
2022―Feb―28 |
Cardiovascular outcome 6 months after severe coronavirus disease 2019 infection |
Anne G. Raafs, Mohammed A. Ghossein, Yentl Brandt, Michiel T.H.M. Henkens, M. Eline Kooi, Kevin Vernooy, Marc E.A. Spaanderman, Suzanne Gerretsen, Susanne van Santen, Rob G.H. Driessen, Christian Knackstedt, Iwan C.C. van der Horst, Bas C.T. van Bussel, Stephane R.B. Heymans, Chahinda Ghossein-Doha |
| 181 |
[GO] |
2022―Feb―15 |
The counter-regulatory arm of the renin-angiotensin system and COVID-19 |
Lucia Federica Stefanelli, Verdiana Ravarotto, Giovanni Bertoldi, Lorenzo A. Calò |
| 182 |
[GO] |
2021―Dec―10 |
Antecedent use of renin-angiotensin system inhibitors is associated with reduced mortality in elderly hypertensive Covid-19 patients |
Mauro Gori, Carlo Berzuini, Emilia D’Elia, Arianna Ghirardi, Luisa Bernardinelli, Antonello Gavazzi, Giulio Balestrieri, Andrea Giammarresi, Roberto Trevisan, Fabiano Di Marco, Antonio Bellasi, Mariangela Amoroso, Federico Raimondi, Luca Novelli, Bianca Magro, Gianpaolo Mangia, Ferdinando L. Lorini, Giulio Guagliumi, Stefano Fagiuoli, Gianfranco Parati, Michele Senni |
| 183 |
[GO] |
2021―Dec―04 |
A low aldosterone/renin ratio and high soluble ACE2 associate with COVID-19 severity |
Sakir Akin, Paula Schriek, Cees van Nieuwkoop, Rugina I. Neuman, Iwan Meynaar, Erik J. van Helden, Hassan El Bouazzaoui, Remon Baak, Marjan Veuger, Ronne A.T.A. Mairuhu, Lettie van den Berg, Vincent van Driel, Loes E. Visser, Evert de Jonge, Ingrid M. Garrelds, Johannes F.A.B. Duynstee, Jan Kees van Rooden, Jeroen Ludikhuize, Koen Verdonk, Kadir Caliskan, Tim Jansen, Ron H.N. van Schaik, A.H. Jan Danser |
| 184 |
[GO] |
2021―Jul―02 |
The interaction of the severe acute respiratory syndrome coronavirus 2 spike protein with drug-inhibited angiotensin converting enzyme 2 studied by molecular dynamics simulation |
Babak Nami, Avrin Ghanaeian, Kasra Ghanaeian, Rozhin Houri, Negin Nami, Armin Ghasemi-Dizgah, Oana Caluseriu |
| 185 |
[GO] |
2021―Jul―02 |
Impact of renin-angiotensin-aldosterone system inhibitor continuation on outcomes for patients with severe coronavirus disease 2019 manifestations |
Alberto Palazzuoli, Kristen M. Tecson, Peter A. McCullough |
| 186 |
[GO] |
2021―Jul―02 |
SARS-CoV-2 infection and ACE2 inhibition |
Fabio Angeli, Gianpaolo Reboldi, Paolo Verdecchia |
| 187 |
[GO] |
2021―Jun―02 |
Cardiovascular system in the sars-CoV-2: impact of therapies |
Josep Redon |
| 188 |
[GO] |
2021―May―12 |
33. CHARACTERISTICS AND COMORBIDITIES OF HYPERTENSIVE PATIENTS IN SANGLAH GENERAL HOSPITAL DURING COVID-19 PANDEMIC |
I Wayan Agus Surya Pradnyana, Gusti Ngurah Prana Jagannatha, Stanly Kamardi, AA Ayu Dwi Adelia Yasmin |
| 189 |
[GO] |
2021―May―12 |
34. BLOOD PRESSURE CONTROL AMONG HYPERTENSIVE PATIENTS IN SANGLAH GENERAL HOSPITAL DURING COVID-19 PANDEMIC |
Stanly Kamardi, Gusti Ngurah Prana Jagannatha, I Wayan Agus Surya Pradnyana, AA Ayu Dwi Adelia Yasmin |
| 190 |
[GO] |
2021―May―12 |
54. COMPARATION OF D-DIMER LEVELS IN HYPERTENSIVE AND NON-HYPERTENSIVE ADULT COVID-19 PATIENTS |
Tantika Andina, Daulat JPM Tampubolon |
| 191 |
[GO] |
2021―May―12 |
77. ASSOCIATION OF D-DIMER AND FIBRINOGEN LEVEL WITH MORTALITY OF HYPERTENSIVE COVID-19 PATIENTS |
V. Damay, C. Sugeng, O. Umboh, E. Moeis |
| 192 |
[GO] |
2021―May―12 |
70. ASSOCIATION BETWEEN HYPERTENSION AND IN-HOSPITAL MORTALITY IN COVID-19 PATIENTS |
Iswandy Janetputra Turu’ Allo, Badai Bhatara Tiksnadi, Pranata Priyo Prakoso, Hana Hadianty Najiyah, Mira Rahmawati, Mira Hasmirani, Robin Hendra Wibowo, Priyanto Utomo, Ade Yudisman |
| 193 |
[GO] |
2021―May―12 |
25. PRO-INFLAMMATORY MARKERS IN COVID-19 PATIENTS WITH HYPERTENSION |
Rizky Andhika, Rudi Supriyadi, Bachti Alisjahbana |
| 194 |
[GO] |
2021―May―12 |
68. ASSOCIATION OF RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM BLOCKER DRUGS AND OUTCOMES IN COVID-19 PATIENTS WITH HYPERTENSION |
Mefri Yanni |
| 195 |
[GO] |
2021―May―12 |
21. THE PROFILE OF COVID-19 PATIENTS WITH HYPERTENSION AT SILOAM DHIRGA SURYA HOSPITAL FROM MAY TO NOVEMBER 2020 |
Epifanus Arie Tanoto, Sri Wahyuni, Abdul Halim Raynaldo |
| 196 |
[GO] |
2021―May―12 |
44. RELATIONSHIP BETWEEN HYPERTENSION AND HYPONATREMIA IN CORONAVIRUS DISEASE PATIENTS: A CROSS-SECTIONAL STUDY |
Ayu Pramitha Wulandari, Dhani Tri Wahyu Nugroho |
| 197 |
[GO] |
2021―Apr―17 |
Relationship between angiotensin-converting enzyme inhibitors or angiotensin receptor blockers and COVID-19 incidence or severe disease |
Gary Tse, Jiandong Zhou, Sharen Lee, Wing Tak Wong, Xintao Li, Tong Liu, Zhidong Cao, Daniel Dajun Zeng, Abraham K.C. Wai, Ian Chi Kei Wong, Bernard Man Yung Cheung, Qingpeng Zhang |
| 198 |
[GO] |
2021―Apr―09 |
IN-HOSPITAL DIURETIC USE IS ASSOCIATED WITH WORSE OUTCOME IN PATIENTS WITH COVID-19 |
M. Pengo, G Stefanini, C Pivato, D Soranna, G Zambra, A Zambon, C Torlasco, G Bilo, G Condorelli, G Parati |
| 199 |
[GO] |
2021―Apr―09 |
ASSOCIATION OF HYPERTENSION WITH ALL-CAUSE MORTALITY AMONG HOSPITALIZED PATIENTS WITH COVID-19 |
Enrique Rodilla, Alberto Saura, Iratxe Jiménez, Andrea Mendizábal, Araceli Pineda-Cantedo, Elizabeth Lorenzo-Hernández, Maria Del Pilar Fidalgo-Montero, Joaquín Fernández López-Cuervo, Ricardo Gil-Sánchez, Elisa Rabadán-Pejenaute, Lucy Abella-Vázquez, Vicente Giner-Galvañ, Marta Nataya Solís-Marquínez, Ramon Boixeda, Andrés De La Peña-Fernández, Francisco Javier Carrasco-Sánchez, Julio González-Moraleja, José David Torres-Peña, María Esther Guisado-Espartero, Joaquín Escobar-Sevilla, Marcos Guzmán-García, María Dolores Martín-Escalante, Ángel Luis Martínez-González, José Manuel Casas-Rojo, Ricardo Gómez-Huelgas |
| 200 |
[GO] |
2021―Apr―09 |
PLASMA ACE2 ACTIVITY IS INCREASED IN PATIENTS RECOVERED FROM SARS-COV-2 INFECTION: IMPLICATIONS FOR THE PROLONGED CONSEQUENCES OF COVID-19 |
Sheila Patel, Jennifer Juno, Wen Shi Lee, Kathleen Wragg, P. Mark Hogarth, Stephen Kent, Louise Burrell |
| 201 |
[GO] |
2021―Apr―09 |
HYPERTENSION PHENOTYPES, TARGET ORGAN DAMAGE AND STIFF ARTERIES AND SEVERITY OF COVID-19 |
Azra Mahmud, Nawaf Abdulaziz Alhabdan, Mohammad Hamad Alkhdiri, Ruba Alahaideb, Rajkumar Rajendrum |
| 202 |
[GO] |
2021―Apr―09 |
HYPERTENSION IS A RISK FACTOR FOR ACUTE KIDNEY INJURY AND A PREDICTOR OF MORTALITY IN HOSPITALIZED PATIENTS WITH COVID-19 |
Yulia Khruleva, Tapiwa Mubayazvamba, Elena Troitskaya, Marina Efremovtseva, Zhanna Kobalava |
| 203 |
[GO] |
2021―Apr―09 |
COMORBIDITIES FACTORS AND HYPERTENSION IN RELATION TO COVID-19 |
Jong Hoon Koh, Enjin Shim, Minjeong Kang, Inkyeong Hwang |
| 204 |
[GO] |
2021―Apr―09 |
THE PREVALENCE OF ARTERIAL HYPERTENSION AMONG PATIENTS HOSPITALIZED WITH COVID-19 |
Kseniia Eruslanova, Anna Akapyan, Irina Malaya, Irina Strojesko, Nikolay Leonov, Julia Kotovskaya, Nadejda Runikhina, Olga Tkacheva |
| 205 |
[GO] |
2021―Apr―09 |
EVIDENCE OF A BLOOD PRESSURE REDUCTION DURING THE COVID-19 ASSOCIATED LOCKDOWN: A PLAUSIBLE EXPLANATION FOR THE OBSERVED DECLINES IN ACUTE CARDIOVASCULAR DISEASES? |
Nicolas Girerd, Christophe Meune, Kevin Duarte, Vincent Vercamer, Marilucy Lopez-Sublet, Jean-Jacques Mourad |
| 206 |
[GO] |
2021―Apr―09 |
LOW MOLECULAR WEIGHT HEPARIN AT HIGH DOSE IMPACTS ON OUTCOME OF COVID-19 HOSPITALIZED PATIENTS, WHILE STANDARD DOSE DOESN’T |
Silvia Bonetti, Gianluca E.M. Boari, Giulia Chiarini, Cristina Faustini, Gianluca Bianco, Federico Braglia-Orlandini, Paolo Malerba, Damiano Rizzoni |
| 207 |
[GO] |
2021―Apr―09 |
HYPERTENSIVE PATIENTS ON TREATMENT AND COVID-19 IN FRANCE: FLAHS 2020 SURVEY |
Olivier Hanon, Atul Pathak, François Silhol, Marie Catherine Wimart, Xavier Girerd |
| 208 |
[GO] |
2021―Apr―09 |
ROLE OF ACE2 GLYCOSYLATION AND RHO KINASE INHIBITION IN THE INFECTIOUS/THERAPEUTIC PROCESS OF COVID-19. INSIGHTS FROM GITELMAN'S AND BARTTER'S SYNDROMES PATIENTS |
Giovanni Bertoldi, Lisa Gianesello, Matteo Rigato, Luca Sgarabotto, Lorenzo Calò |
| 209 |
[GO] |
2021―Apr―09 |
IMPACT OF COVID-19 LOCKDOWN ON VASCULAR STIFFNESS TRAJECTORIES IN FRANCE AND GERMANY |
Rosa Maria Bruno, Jean-Louis Pepin, Jean-Philippe Empana, Rui-Yi Yang, Vincent Vercamer, Paul Jouhaud, Pierre Escorrou, Pierre Boutouyrie |
| 210 |
[GO] |
2021―Apr―09 |
INCREASED CARDIOVASCULAR DEATH RATES IN A COVID-19 LOW PREVALENCE AREA |
Rita Del Pinto, Giovambattista Desideri, Leondino Mammarella, Stefano Abballe, Sofia Dell’Anna, Sabrina Cicogna, Davide Grassi, Simona Sacco, Claudio Ferri |
| 211 |
[GO] |
2021―Apr―09 |
CARDIOVASCULAR COMPLICATIONS FROM COVID-19 MAY BE PREDICTED BY THE INCREASED LEVEL OF C-REACTIVE PROTEIN: A META-ANALYSIS |
Elona Greca, Muhammad Shah, Krunal Pandav, Dario Dedja, Ilda Hoxhaj |
| 212 |
[GO] |
2021―Apr―09 |
ADHERENCE TO ANTI-HYPERTENSIVE TREATMENT ON THE COVID-19 PANDEMIC |
Mayra Cristina Luz Pádua Guimaraes, Juliana Chaves Coelho, Juliano Dos Santos, Camila Braga De Oliveira Higa, Carime Farah Florido, Renata Jae Won Lee, Grazielli Pessoa Soares, Giovanio Vieira Da Silva, Angela Maria Geraldo Pierin |
| 213 |
[GO] |
2021―Apr―09 |
PATIENTS’ PERCEPTIONS ON THE USE OF RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM INHIBITORS DURING THE FIRST WAVE OF THE COVID-19 PANDEMIC |
Antonios Ioannidis, Maria Paraskelidou, Apostolos Pechlevanis, Afroditi Fragkiskou |
| 214 |
[GO] |
2021―Apr―09 |
THE IMPACT OF COVID-19 PANDEMIC AND LOCKDOWN ON CARDIOMETABOLIC STATUS ON PATIENTS WITHOUT EVIDENCE OF SARS COV-2 INFECTION IN THREE REGIONS OF LATIN AMERICA. A SUB-STUDY OF THE CORCOVID LATAM STUDY |
Jorge Camilletti, Nicolas Renna, Ricardo Lopez Santi, Juan Erriest, Grecia Perez Siller, Maria Isabel Garcia, Carlos Garcia Martinez, Adrian Baranchuk |
| 215 |
[GO] |
2021―Apr―09 |
THE IMPACT OF COVID-19 PANDEMIC LOCKDOWN ON HYPERTENSIVE INDIVIDUALS WITH COMORBIDITIES OF A LONGITUDINAL COHORT IN INDIA |
Kaushik Chakraborty, Nilanjana Chakraborty, Ramendra Nath Mitra, Dipra Mitra |
| 216 |
[GO] |
2021―Apr―09 |
PATIENTS’ PERCEPTIONS ON THE USE OF RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM INHIBITORS: COMPARISON BETWEEN THE FIRST AND THE SECOND COVID-19 PANDEMIC WAVES |
Antonios Ioannidis, Apostolos Pechlevanis, Afroditi Fragkiskou, Maria Paraskelidou |
| 217 |
[GO] |
2021―Apr―09 |
IMPACT OF REDUCTION IN AIRCRAFT NOISE EXPOSURE ON BLOOD PRESSURE AND ARTERIAL STIFFNESS DURING COVID-19 PANDEMIC: CROSS-SECTIONAL AND LONGITUDINAL STUDY |
Wiktoria Wojciechowska, Andrzej Januszewicz, Tomasz Drozdz, Marta Rojek, Justyna Baczalska, Michal Terlecki, Karol Kurasz, Agnieszka Olszanecka, Mikolaj Smolski, Aleksander Prejbisz, Piotr Dobrowolski, Tomasz Hryniewiecki, Reinhold Kreutz, Marek Rajzer |
| 218 |
[GO] |
2021―Apr―09 |
CONDUCTING AN RCT IN THE COVID-19 PANDEMIC: TARGETING VULNERABILITY TO SEASONAL AND ACUTE WEATHER CHANGES TO KEEP AUSTRALIANS WITH CARDIOVASCULAR DISEASE OUT OF HOSPITAL - THE RES |
Nasreen Moini, Sheila K. Patel, Jay Ramchand, Jody Hook, Christine F. Mcdonald, Simon Stewart, Louise Burrell |
| 219 |
[GO] |
2021―Apr―09 |
HYPERTENSION ASSOCIATED RISKS DURING THE COVID-19 PANDEMIC: THE PATIENTS’ PERCEPTION |
Antonios Ioannidis, Afroditi Fragkiskou, Maria Paraskelidou, Apostolos Pechlevanis |
| 220 |
[GO] |
2021―Apr―09 |
HYPERTENSION AND COVID-19: THE POSSIBLE ROLE OF METALLOPROTEINASE-9 IN COVID-19 PATHOPHYSIOLOGY |
Carolina Dávila Mesquita, Ariel Emiliano Souza Do Couto, Ligia Borges Campos, Bruno Cesar Petroski Mora, Fabiola Mestriner, Tauana Fernandes Vasconcelo, Jessyca Michelon Barbosa, Carlos Curylofo Corsi, Denise Ferro, Mauricio Serra Ribeiro, Mayra Gonçalves Menegueti, M. Auxiliadora Martins, Christiane Becari |
| 221 |
[GO] |
2021―Apr―09 |
ASSOCIATION OF ARTERIAL STIFFNESS WITH ALL-CAUSE MORTALITY AMONG HOSPITALIZED COVID-19 PATIENTS |
Enrique Rodilla, Alberto Belda, Sergio Canales, Maria Quilis, Maria Carmen Saez, Alicia Roldan, Xavi Cortes, Marta Aguilar, Amparo Albert, Marta Garijo, Tamara Malek, Marta Palop, Jorge Pinel, Inmaculada Salvador, Vanesa Sanchez, Julio Vicente, Alberto Saura, Iratxe Jimenez, Andrea Mendizabal, Amparo Lloris, Bianca Ridaura, Zinneb Karroud, Angela Nicolas, Santiago Morro, Monica Fernandez, Noemi Beltran, Sandra Reino, Amparo Carmena, Angela Gag, Jose Maria Pascual |
| 222 |
[GO] |
2021―Apr―09 |
ROLE OF HYPERTENSION, CARDIOVASCULAR DISEASE AND CARDIOVASCULAR RISK FACTORS ON OUTCOME IN HOSPITALIZED COVID-19 PATIENTS |
Giulia Chiarini, Gianluca E.M. Boari, Silvia Bonetti, Federico Braglia Orlandini, Paolo Malerba, Gianluca Bianco, Cristina Faustini, Damiano Rizzoni |
| 223 |
[GO] |
2021―Apr―09 |
EFFECT OF ONGOING TREATMENT AND DIFFERENT THERAPIES ON PROGNOSIS IN COVID-19 PATIENTS IN AN HOSPITAL SETTING |
Gianluca Bianco, Gianluca E.M. Boari, Silvia Bonetti, Giulia Chiarini, Federico Braglia Orlandini, Cristina Faustini, Paolo Malerba, Damiano Rizzoni |
| 224 |
[GO] |
2021―Apr―09 |
GENDER DIFFERENCES IN COVID-19 PATIENTS WITH ARTERIAL HYPERTENSION |
Tiziana Ciarambino, Filippina Ciaburri, Vera Delli Paoli, Marinella D’avino, Direttivo Fadoi Campania |
| 225 |
[GO] |
2021―Apr―09 |
ROLE OF HYPERTENSION ON THE SEVERITY AND PROGRESSION OF COVID-19: A RETROSPECTIVE COHORT STUDY IN INDIA |
Ambily K, Tapas Sadasivan Nair |
| 226 |
[GO] |
2021―Apr―09 |
RENIN-ANGIOTENSIN SYSTEM INHIBITORS AND COVID-19: A SYSTEMATIC REVIEW AND META-ANALYSIS EVIDENCE FOR SIGNIFICANT GEOGRAPHICAL DISPARITIES |
Dimitrios Patoulias, Alexandra Katsimardo, Konstantinos Stavropoulo, Konstantinos Imprialos, Maria -Styliani Kalogirou, Michael Doumas |
| 227 |
[GO] |
2021―Apr―09 |
LEVELS OF IMMUNOGLOBULIN G AND MARKERS OF VASCULAR INFLAMMATORY RESPONSE AS PREDICTORS OF POSSIBLE VASCULAR COMPLICATIONS IN PATIENTS WITH ARTERIAL HYPERTENSION AFTER SARS-COV-2 |
Tatiana Petelina, Musikhina Natalia, Yaroslavskaya Elena, Gultyaeva Elena, Avdeeva Ksenia, Gorbatenko Elena, Gapon Lyudmila, Zueva Ekaterina, Shcherbinina Anastasia |
| 228 |
[GO] |
2021―Apr―09 |
SKIN CAPILLARY ALTERATIONS IN PATIENTS WITH ACUTE SARS-COV-2 INFECTION |
Carolina De Ciuceis, Claudia Agabiti Rosei, Valeria Brami, Claudia Rossini, Andrea Gaggero, Francesca Fama’, Maria Lorenza Muiesan, Damiano Rizzoni |
| 229 |
[GO] |
2021―Apr―09 |
IMPACT OF COVID 19 PANDEMIC ON BLOOD PRESSURE OF HEALTHCARE PROFESSIONALS DURING LOCKDOWN - AN INDIAN STUDY |
Amit Gupta, Anuj Maheshwari, Narsingh Verma, Aravinda Jagadeesha, S.S. Dariya, Amit Sharma, Divya Saxena, Anubha Srivastava, Bijay Patni, Deepak Das, Amrit Kaur, Amitesh Aggarwal, Padmashri Gulati, Saurabh Srivastava, Arti Agnihotri |
| 230 |
[GO] |
2021―Mar―03 |
Lessons from COVID-19 mortality data across countries |
Giovanni Corrao, Federico Rea, Gian Carlo Blangiardo |
| 231 |
[GO] |
2021―Mar―03 |
Coronavirus disease 2019 and cardiovascular complications |
Sahrai Saeed, Marijana Tadic, Terje H. Larsen, Guido Grassi, Giuseppe Mancia |
| 232 |
[GO] |
2021―Feb―22 |
Renin-angiotensin-system inhibitors and all-cause mortality in patients with coronavirus disease 2019 |
Chirag Bavishi, Paul K. Whelton, Giuseppe Mancia, Giovanni Corrao, Franz H. Messerli |
| 233 |
[GO] |
2020―Dec―31 |
Lifestyle, psychological, socioeconomic and environmental factors and their impact on hypertension during the coronavirus disease 2019 pandemic |
Reinhold Kreutz, Piotr Dobrowolski, Aleksander Prejbisz, Engi A.E-H Algharably, Grzegorz Bilo, Felix Creutzig, Guido Grassi, Vasilios Kotsis, Dragan Lovic, Empar Lurbe, Pietro A. Modesti, Marco Pappaccogli, Gianfranco Parati, Alexandre Persu, Jorge Polonia, Marek Rajzer, Philippe de Timary, Thomas Weber, Burkhard Weisser, Konstantinos Tsioufis, Giuseppe Mancia, Andrzej Januszewicz |
| 234 |
[GO] |
2020―Dec―04 |
The corona-virus disease 2019 pandemic compromised routine care for hypertension: a survey conducted among excellence centers of the European Society of Hypertension |
|
| 235 |
[GO] |
2020―Nov―17 |
Evaluating sources of bias in observational studies of angiotensin-converting enzyme inhibitor/angiotensin II receptor blocker use during coronavirus disease 2019 |
Jordana B. Cohen, Lucy D’Agostino-McGowan, Elizabeth T. Jensen, Joseph Rigdon, Andrew M. South |
| 236 |
[GO] |
2020―Nov―04 |
Renin--angiotensin system blockers and the risk of critical or fatal coronavirus disease 2019 in African Americans |
Costas Thomopoulos, Helena Michalopoulou |
| 237 |
[GO] |
2020―Oct―06 |
Association between renin-angiotensin-aldosterone system blockers and outcome in coronavirus disease 2019 |
Alexandre Lahens, Jimmy Mullaert, Simon Gressens, Nathalie Gault, Martin Flamant, Laurène Deconinck, Véronique Joly, Yazdan Yazdanpanah, François-Xavier Lescure, Emmanuelle Vidal-Petiot |
| 238 |
[GO] |
2020―Aug―05 |
Immunity, inflammation and the vasculature in the COVID-19 era |
Aletta E. Schutte, David G. Harrison |
| 239 |
[GO] |
2020―Aug―05 |
Association between hypertension and pneumonia caused by SARS-CoV-2 in Mexican population |
Akram Hernández-Vásquez, Rodrigo Vargas-Fernández, Guido Bendezu-Quispe |
| 240 |
[GO] |
2020―Aug―03 |
Baseline use of angiotensin-converting enzyme inhibitor/AT1 blocker and outcomes in hospitalized coronavirus disease 2019 African-American patients |
Priyank Shah, Jack Owens, James Franklin, Yash Jani, Ashish Kumar, Rajkumar Doshi |
| 241 |
[GO] |
2020―Jun―05 |
Are COVID-19 patients with hypertension at higher risk in China? |
Siqi Wang, Yan Chen, Lu Wang, Huan Liu, Ping Han |
| 242 |
[GO] |
2020―May―30 |
Food protein-derived antihypertensive peptides in the COVID-19 pandemic |
Mostafa Goudarzi, Farhad Garavand, Ashkan Madadlou, Vincenzo Fogliano |
| 243 |
[GO] |
2020―May―08 |
Influence of inhibitors of the renin-angiotensin system on risk of acute respiratory distress syndrome in Danish hospitalized COVID-19 patients |
Anders Holt, Ikram Mizrak, Morten Lamberts, Per Lav Madsen |
| 244 |
[GO] |
2020―May―06 |
COVID-19, hypertension and angiotensin receptor-blocking drugs |
Francisco José Fernández-Fernández |
| 245 |
[GO] |
2020―May―06 |
Comment on ‘Can angiotensin receptor-blocking drugs perhaps be harmful in the COVID-19 pandemic?’ |
Erkan Cüre, Medine Cumhur Cüre |
| 246 |
[GO] |
2020―May―06 |
Angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers and coronavirus |
Paolo Verdecchia, Fabio Angeli, Gianpaolo Reboldi |
| 247 |
[GO] |
2020―May―06 |
Hypertension and coronavirus disease 2019 |
Ari G. Mandler |
| 248 |
[GO] |
2020―May―06 |
Hypertension and coronavirus disease 2019 mortality |
Ruben Kevin A. Tapia-Orihuela |
| 249 |
[GO] |
2020―May―06 |
Could renin-angiotensin-aldosterone system inhibitors be used for hypertensive patients with coronavirus disease 2019? |
Di Liu, Yun-Zhao Li, Hui Wu |
| 250 |
[GO] |
2020―May―06 |
Angiotensin-converting enzyme-2 in SARS-CoV-2 infection |
Jorie Versmissen, Koen Verdonk, Melvin Lafeber, Johannes P.C. van den Akker, Nicole G.M. Hunfeld, Ewout J. Hoorn, A.H. Jan Danser |
| 251 |
[GO] |
2020―Mar―20 |
Can angiotensin receptor-blocking drugs perhaps be harmful in the COVID-19 pandemic? |
Murray Esler, Danielle Esler |
|
